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A B S T R A C T
Background
Self-harm (SH; intentional self-poisoning or self-injury) is common in children and adolescents, often repeated, and strongly associated
with suicide. This is an update of a broader Cochrane review on psychosocial and pharmacological treatments for deliberate SH first
published in 1998 and previously updated in 1999. We have now divided the review into three separate reviews; this review is focused
on psychosocial and pharmacological interventions for SH in children and adolescents.
Objectives
To identify all randomised controlled trials of psychosocial interventions, pharmacological agents, or natural products for SH in children
and adolescents, and to conduct meta-analyses (where possible) to compare the effects of specific treatments with comparison types of
treatment (e.g., treatment as usual (TAU), placebo, or alternative pharmacological treatment) for children and adolescents who SH.
Search methods
For this update the Cochrane Depression, Anxiety and Neurosis Group (CCDAN) Trials Search Co-ordinator searched the CCDAN
Specialised Register (30 January 2015).
Selection criteria
We included randomised controlled trials comparing psychosocial or pharmacological treatments with treatment as usual, alternative
treatments, or placebo or alternative pharmacological treatment in children and adolescents (up to 18 years of age) with a recent (within
six months) episode of SH resulting in presentation to clinical services.
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Data collection and analysis
Two reviewers independently selected trials, extracted data, and appraised study quality, with consensus. For binary outcomes, we
calculated odds ratios (OR) and their 95% confidence intervals (CI). For continuous outcomes measured using the same scale we
calculated the mean difference (MD) and 95% CI; for those measured using different scales we calculated the standard mean difference
(SMD) and 95% CI. Meta-analysis was only possible for two interventions: dialectical behaviour therapy for adolescents and group-
based psychotherapy. For these analyses, we pooled data using a random-effects model.
Main results
We included 11 trials, with a total of 1,126 participants. The majority of participants were female (mean = 80.6% in 10 trials reporting
gender). All trials were of psychosocial interventions; there were none of pharmacological treatments. With the exception of dialectical
behaviour therapy for adolescents (DBT-A) and group-based therapy, assessments of specific interventions were based on single trials.
We downgraded the quality of evidence owing to risk of bias or imprecision for many outcomes.
Therapeutic assessment appeared to increase adherence with subsequent treatment compared with TAU (i.e., standard assessment; n =
70; k = 1; OR = 5.12, 95% CI 1.70 to 15.39), but this had no apparent impact on repetition of SH at either 12 (n = 69; k = 1; OR
0.75, 95% CI 0.18 to 3.06; GRADE: low quality) or 24 months (n = 69; k = 1; OR = 0.69, 05% CI 0.23 to 2.14; GRADE: low quality
evidence). These results are based on a single cluster randomised trial, which may overestimate the effectiveness of the intervention.
For patients withmultiple episodes of SHor emerging personality problems,mentalisation therapywas associatedwith fewer adolescents
scoring above the cut-off for repetition of SH based on the Risk-Taking and Self-Harm Inventory 12 months post-intervention (n =
71; k = 1; OR = 0.26, 95% CI 0.09 to 0.78; GRADE: moderate quality). DBT-A was not associated with a reduction in the proportion
of adolescents repeating SH when compared to either TAU or enhanced usual care (n = 104; k = 2; OR 0.72, 95% CI 0.12 to 4.40;
GRADE: low quality). In the latter trial, however, the authors reported a significantly greater reduction over time in frequency of
repeated SH in adolescents in the DBT condition, in whom there were also significantly greater reductions in depression, hopelessness,
and suicidal ideation.
We found no significant treatment effects for group-based therapy on repetition of SH for individuals with multiple episodes of SH at
either the six (n = 430; k = 2; OR 1.72, 95% CI 0.56 to 5.24; GRADE: low quality) or 12 month (n = 490; k = 3; OR 0.80, 95%
CI 0.22 to 2.97; GRADE: low quality) assessments, although considerable heterogeneity was associated with both (I2 = 65% and 77%
respectively). We also found no significant differences between the following treatments and TAU in terms of reduced repetition of
SH: compliance enhancement (three month follow-up assessment: n = 63; k = 1; OR = 0.67, 95% CI 0.15 to 3.08; GRADE: very
low quality), CBT-based psychotherapy (six month follow-up assessment: n = 39; k = 1; OR = 1.88, 95% CI 0.30 to 11.73; GRADE:
very low quality), home-based family intervention (six month follow-up assessment: n = 149; k = 1; OR = 1.02, 95% CI 0.41 to 2.51;
GRADE: low quality), and provision of an emergency card (12 month follow-up assessment: n = 105, k = 1; OR = 0.50, 95% CI 0.12
to 2.04; GRADE: very low quality). No data on adverse effects, other than the planned outcomes relating to suicidal behaviour, were
reported.
Authors’ conclusions
There are relatively few trials of interventions for children and adolescents who have engaged in SH, and only single trials contributed
to all but two comparisons in this review. The quality of evidence according to GRADE criteria was mostly very low. There is little
support for the effectiveness of group-based psychotherapy for adolescents with multiple episodes of SH based on the results of three
trials, the evidence from which was of very low quality according to GRADE criteria. Results for therapeutic assessment, mentalisation,
and dialectical behaviour therapy indicated that these approaches warrant further evaluation. Despite the scale of the problem of SH
in children and adolescents there is a paucity of evidence of effective interventions. Further large-scale trials, with a range of outcome
measures including adverse events, and investigation of therapeutic mechanisms underpinning these interventions, are required. It is
increasingly apparent that development of new interventions should be done in collaboration with patients to ensure that these are
likely to meet their needs. Use of an agreed set of outcome measures would assist evaluation and both comparison and meta-analysis
of trials.
P L A I N L A N G U A G E S U M M A R Y
Interventions for children and adolescents who self-harm
Why is this review important?
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Self-harm (SH), which includes intentional self-poisoning/overdose and self-injury, is a major problem in children and adolescents in
many countries and is strongly linked to risk of future suicide. It is therefore important that effective treatments for SH patients are
developed.
Who will be interested in this review?
Clinicians working with young people who engage in SH, policy makers, young people who themselves have self-harmed or may be at
risk of doing so, and their families and relatives.
What questions does this review aim to answer?
This review is an update of a previous Cochrane review from 1999 which found little evidence of beneficial effects of interventions for
SH aimed specifically at children and adolescents. This update aims to further evaluate the evidence for the effectiveness of psychosocial
and pharmacological treatments for children and adolescents who engage in SH with a broader range of outcomes, particularly with
regards to investigating whether there are specific treatments for children and adolescents who SHwhich have greater benefit compared
to routine care in terms of treatment adherence and improvements in psychological well-being.
Which studies were included in the review?
To be included in the review, studies had to be randomised controlled trials of either psychosocial or pharmacological treatments for
children and adolescents up to 18 years of age who had recently engaged in SH and presented to clinical services.
What does the evidence from the review tell us?
There have been surprisingly few investigations of treatments for SH in children and adolescents, despite the size of this problem in
many countries. Providing therapeutic assessment may improve attendance at subsequent treatment sessions. Only one therapeutic
approach - mentalisation - was associated with a reduction in frequency of repetition of SH. However this effect was only modest and
the trial was small, which prevents us from being able to make firm conclusions about the effectiveness of this treatment. There was
no clear evidence of effectiveness for compliance enhancement, individual cognitive behavioral therapy (CBT)-based psychotherapy,
home-based family intervention, or provision of an emergency card, nor was there clear evidence for group therapy for adolescents with
a history of multiple episodes of SH.
What should happen next?
Therapeutic assessment, mentalisation, and dialectical behaviour therapy warrant further investigation. While in a single small study,
individual CBT-based psychotherapy appeared ineffective, further evaluation of this treatment is also desirable given the favourable
results found in adults who SH.Given the extent of SH in children and adolescents, greater attention should be paid to the development
and evaluation of specific therapies for this population.
3Interventions for self-harm in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
CBT-based psychotherapy compared to treatment as usual
Patient or population: children and adolescents who engage in SH.
Settings: outpat ient.
Intervention: individual CBT-based psychotherapy.
Comparison: t reatment as usual.
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Treatment as usual CBT-based
psychotherapy
Repetition of SH at six
months
Study population OR 1.88
(0.3 to 11.73)
39
(1 RCT)
⊕©©©
VERY LOW1,2
Quality was down-
graded as information
on allocat ion conceal-
ment, part icipant blind-
ing, outcome asses-
sor blinding, and selec-
t ive outcome report ing
was not adequately de-
scribed. The trial was
further downgraded as
the same therapists de-
livered both the in-
tervent ion and control
treatments leading to
possible confounding
which could have led
to a reduct ion in the
demonstrated ef fect
111 per 1000 190 per 1000
(36 to 595)
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* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CBT: cognit ive behavioural therapy; CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SH: self -harm.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was rated as VERY SERIOUS as information on allocat ion concealment, part icipant blinding, outcome
assessor blinding, and select ive outcome report ing was not adequately described raising the possibility of select ion bias,
performance bias, detect ion bias, and report ing bias. Given that the same therapists delivered both the intervent ion and
control treatments in this trial, there is also the possibility of confounding which could have led to a reduct ion in the
demonstrated ef fect.
2 Imprecision was rated as SERIOUS owing to the wide conf idence interval associated with the est imate of treatment ef fect.
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B A C K G R O U N D
Description of the condition
The term ‘self-harm’ is used to describe all intentional acts of self-
poisoning (such as overdoses) or self-injury (such as self-cutting),
irrespective of degree of suicidal intent or other types of motiva-
tion (Hawton 2003). Thus it includes acts intended to result in
death (‘attempted suicide’), those without suicidal intent (for ex-
ample, to communicate distress, to temporarily reduce unpleasant
feelings), and those with mixed motivation (Hjelmeland 2002;
Scoliers 2009). The term ‘parasuicide’ was introducedbyKreitman
1969 to include the same range of behaviour. However, ‘parasui-
cide’ has been used in the USA to refer specifically to acts of self-
harm without suicidal intent (Linehan 1991), and the term has
largely fallen into disuse in the UK and other countries. In the
fifth version of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-5; American Psychiatric Association 2013), two
types of self-harming behaviour are included as conditions for fur-
ther study, namely “Non-Suicidal Self Injury” (NSSI) and “Suici-
dal Behavior Disorder” (SBD). Many researchers and clinicians,
however, believe this to be an artificial and somewhat misleading
categorisation (Kapur 2013), and recent research has shown a high
level of co-occurance betweenNSSI and attempted suicide, in par-
ticular among young people (Andover 2012). We have therefore
used the approach favoured in the UK and some other countries
of conceptualising all intentional self-harm in a single category,
namely self-harm (SH).
SH is a major problem in children and adolescents (Hawton
2012a). Unlike suicide, in most countries SH in young people oc-
curs far more commonly in females than males (Evans 2005). SH
is uncommon below the age of 12 years (Hawton 2003); from age
12 years onwards, SH becomes increasingly frequent in girls such
that the female:male ratio between 12 and 15 years of age is as
high as five or six to one. This is thought to be due to the increased
prevalence of depression in young adolescent females, and alcohol
consumption and engagement in sexual activity in both genders
(Patton 2007). The gender ratio decreases in the older teenage
years as the behaviour becomes more frequent in boys and rates
level off in girls. SH is more frequent in adolescents from lower so-
cioeconomic groups (Burrows 2010). In the UK, SH has become
more common in adolescents in recent decades, at least as reflected
in hospital presentations (Hawton 2003). However, only about
one in eight adolescents in the community who self-report en-
gaging in SH ever presents to hospital (Hawton 2002; McMahon
2014; Ystgaard 2009). In fact, it has become increasingly apparent
that SH in adolescents in the community (without hospital pre-
sentation) is extremely common (Hawton 2012a; Madge 2008;
McMahon 2014), although less is known about these individuals.
In children and adolescents who present to hospital, the most
common method of SH is self-poisoning, with overdoses of anal-
gesics (especially paracetamol) being common in some countries,
particularly those of high income (Hawton 2012b; Sheen 2002).
In a multicentre study of child and adolescent SH presentations
to hospitals in England, three-quarters of individuals were girls
and self-poisoning occurred in just over three-quarters of episodes
(Hawton 2012b). Self-cutting is the next most frequent method
for those who present to hospital. In the community, however, self-
cutting and other forms of self-mutilation are far more frequent
than self-poisoning (Madge 2008).
SH (and suicide) in adolescents is the result of a complex inter-
play between genetic, biological, psychiatric, psychosocial, social,
and cultural factors (Hawton 2012a). Relationship problems are
common in adolescents who engage in SH, especially problems
with family members. Relationship problems with partners are
more common in older adolescents than in younger adolescents
(Hawton 2012b); there may also be a history of emotional, phys-
ical, or sexual abuse (Madge 2011). Bullying, including cyberbul-
lying, can also increase the risk of SH (Hinduja 2010). Psychiatric
disorders are common in adolescents who present to hospital be-
cause of SH, with depression, anxiety, ADHD, and eating disor-
ders being particularly frequent (Hawton 2013). While person-
ality disorders should not be diagnosed in adolescents, emergent
pathological personality traits may be apparent during this phase
of development, with traits similar to those in adult borderline
personality disorder being found in some adolescents who engage
in frequent repetition of SH (Crowell 2012). Poor emotion regu-
lation abilities or poor emotional intelligence may also contribute
to the risk of SH in this population (Mikolajczak 2009).
SH in adolescence often has a ’contagious’ quality, and exposure to
SH (and suicide) in friends and familymembers can be a strong in-
fluence (Hawton 2002; McMahon 2013; O’Connor 2014). Ado-
lescents are also vulnerable to media influences; SH in both tradi-
tional media, such as films and television soaps, and new media,
especially the Internet and social networking (Daine 2013), are
important.
Psychological influences on SH in young people include feelings
of entrapment, lack of belonging, and perceiving oneself as a bur-
den (O’Connor 2012). Deficiencies in problem-solving skills may
also be relevant (Speckens 2005). Other contributors include per-
fectionism, low self-esteem, social isolation, impulsivity, hopeless-
ness, and poor parent-child attachment (Hawton 2012a). On the
other hand, social attachment to family (Carter 2007), friends,
and school may be protective (King 2008; Stallard 2013).
Repetition of SH is common in adolescents, with 15-25% of in-
dividuals who present to hospital following SH returning to the
same hospital following a repeat episode within a year (Hawton
2008b). There may also be other repeat episodes that do not result
in hospital presentation. Repetition is also common in adolescents
who do not present to clinical care (Hawton 2002).
While suicide is relatively uncommon in younger adolescents, SH
generally increases the risk of future suicide, especially in adoles-
cent males. Risk is also increased in those who repeat SH and,
contrary to clinical opinion, possibly in those who cut them-
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selves (compared to those who engage in self-poisoning) (Hawton
2012c).
Of particular concern regarding after-care of adolescents who en-
gage SH and who present to hospital is the fact that adherence
to recommended treatment tends to be relatively poor; between
25% and 50% of adolescents will not attend any follow-up ses-
sions (Granboulan 2001; Taylor 1984).
Description of the intervention
Treatment for SH in children and adolescents may involve psy-
chosocial interventions, pharmacological interventions, or a com-
bination of the two approaches.
Psychosocial interventions
Given the role of psychological influences, and particularly prob-
lem-solving deficits (Speckens 2005), in children and adolescents
who engage in SH, psychological approaches used in the treatment
of these individuals typically involve brief individual or group-
based psychological therapy (such as cognitive-behavioural ther-
apy or problem-solving therapy), family therapy, and contact in-
terventions; enhanced assessment interventions may also be used.
Treatment may vary in terms of initial management, location of
treatment, continuity, and intensity or frequency of contact with
therapists. There is also considerable variation among countries in
the availability of services to provide such interventions. Conse-
quently, there is no standard psychosocial treatment for SH in chil-
dren and adolescents. However, in high income countries treat-
ment generally consists of a combination of assessment, support,
involvement of relatives, and individual psychological therapies.
Pharmacological interventions
Given the prevalence of depression in children and adolescents
who present to hospital following an episode of SH (Hawton
2013), pharmacological treatments may include antidepressants.
Other pharmacological agents, such as benzodiazepines and other
anxiolytics, may also be prescribed.However, treatmentwith phar-
macological agents is generally less common than treatment with
psychosocial interventions, partly due to concerns about the risk
of exacerbating suicidality (Miller 2014).
How the intervention might work
Psychosocial interventions
The mechanisms of action of psychosocial interventions might
include helping adolescents improve their coping skills and tackle
specific problems, overcoming psychiatric disorders, improving
self-esteem, increasing a sense of social connectedness, and reduc-
ing impulsivity, aggression, and unhelpful reactions to distressing
situations.
Cognitive behavioural therapy-based psychotherapy
This intervention includes both cognitive behavioural therapy
(CBT) and problem-solving therapy (PST). CBT helps patients
identify and critically evaluate the ways inwhich they interpret and
evaluate disturbing emotional experiences and events (Westbrook
2011), and aims to help them change the ways in which they
deal with problems. This is achieved in three steps: first, patients
are helped to change the ways in which they interpret and evalu-
ate distressing emotions; second, patients learn strategies to help
them change the way in which they think about the meanings and
consequences of these emotions; finally, with the benefit of modi-
fied interpretation of emotions and events, patients are helped to
change their behaviour and develop positive functional behaviour
(Jones 2012).
PST, which is an integral part of CBT, assumes that ineffective
and maladaptive coping behaviours might be overcome by help-
ing patients learn skills to actively, constructively, and effectively
solve the problems they face in their daily lives (Nezu 2010), and
that this will reduce SH. PST consists of encouraging patients to
consciously and rationally appraise problems, reduce or modify
the negative emotions generated by problems, and develop a range
of possible solutions to address problems (D’Zurilla 2010). Treat-
ment goals include helping patients to develop a positive prob-
lem-solving orientation, use rational problem-solving strategies,
reduce the tendency to avoid problem-solving, and reduce the use
of impulsive problem-solving strategies (Washburn 2012). Home-
work assignments are an essential component of CBT-based psy-
chotherapy.
Interventions for patients with multiple episodes of SH or
emerging personality problems
Dialectical behaviour therapy
Dialectical behaviour therapy (DBT) in adults combines problem-
solving training, skills training, cognitive modification training,
and mindfulness techniques (Washburn 2012), encouraging pa-
tients to accept their thoughts, feelings, and behaviours without
necessarily attempting to change, suppress, or avoid these expe-
riences (Lynch 2006). Within this framework, the aim of DBT
is to help patients better regulate their emotions, achieve a sense
of interpersonal effectiveness, become more tolerant of distressing
thoughts or feelings, and become better at managing their own
thoughts and behaviours (Linehan 1993; Linehan 2007). The pri-
mary treatment goals of DBT are therefore threefold: to reduce
SH, behaviours that interfere with the success of treatment (such
as treatment non-adherence), and any other factors which may
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adversely affect the patent’s quality of life (such as frequency or
duration of psychiatric hospitalizations) (Linehan 1993).
Dialectical Behaviour Therapy for Adolescents (DBT-A) is a clin-
ical programme for adolescents with severe personality difficulties
and co-morbid mental health problems. DBT-A has been adapted
by Miller 2007 from Linehan’s initial conceptualisation of DBT
which was developed for adults diagnosed with borderline person-
ality disorder. DBT-A typically includes a combination of indi-
vidual and family sessions (Mehlum 2014). As the aim of DBT-A
is to help adolescents change or adjust to maladaptive personality
characteristics, the treatment is intensive and relatively prolonged,
although usually less so than in adults (James 2008; Miller 2007).
Mentalisation
Mentalisation refers to the ability to understand the actions of
both the self and of others as meaningful given knowledge of the
desires, beliefs, feelings, emotions, and motivations that under-
score the behaviour (Bateman 2004; Choi-Kain 2008). During
times of interpersonal stress, however, individuals may fail to rep-
resent experiences in terms of mental states, and instead become
overwhelmed with negative thoughts and feelings about the self
(Rossouw 2013). Behaviours such as SH may therefore represent
an escape from these negative self-evaluations. Mentalisation ther-
apy aims to improve patients’ ability to empathise with others by
developing an understanding of how their own behaviours may
impact on the feelings of others, and to regulate their own emo-
tions more effectively (Rossouw 2013).
Group-based psychotherapy
In the treatment of adolescents who have engaged in SH, group
psychotherapy has included the integration of techniques from
several therapies, including CBT, DBT-A, and specific group tech-
niques (Green 2011; Wood 2001a). In adolescents, group-based
psychotherapy may be more effective than individual psychother-
apy as it provides patients with a chance to work on skills re-
lated to developing interpersonal relationships and problem-solv-
ing, which are deficient in some suicidal adolescents (Evans 2004;
Speckens 2005).
Enhanced assessment approaches
Therapeutic assessment combines standard psychosocial history
and risk assessment techniqueswith cognitive-analytic therapy and
PST (Ougrin 2011a). Adolescents learn to identify sources of psy-
chological pain and their connection to problem behaviours such
as SH, and identify ways to break this cycle. The aim is to enhance
adherence with subsequent treatment and therefore potential ben-
efit from it.
Compliance enhancement approaches
Given the known poor treatment adherence of adolescents who
engage in SH (Granboulan 2001; Taylor 1984), efforts to main-
tain contact with patients, such as following up patients in the
community, as well as efforts to address factors likely to impede at-
tendance at treatment sessions may be used to enhance treatment
engagement and adherence (Spirito 2002).
Home-based family interventions
Home-based family intervention typically involves conjoint ther-
apy sessions with the child or adolescent and family members.
It includes negotiation of goals, exploration of the SH episode,
communication between family members, problem solving, and
discussion of developmental issues and their impact on the family.
The basis of this therapy is that SH in young people may relate
to family dysfunction and that this therapeutic approach could
help families function better and hence reduce the risk of suicidal
ideation and SH (Harrington 1998).
Remote contact interventions
Contact interventions, particularly emergency card interventions,
can be used to encourage patients to seek help when they feel
distressed as well as offering provision of on-demand emergency
contact with psychiatric services (Kapur 2010). In adolescents this
has been used as a means of gaining admission to psychiatric in-
patient care (Cotgrove 1995). The aim is to reduce the risk of SH
by facilitating rapid access to care.
Pharmacological interventions
Antidepressants
Antidepressants might be expected to have general benefits on
mood in young people with depression and, hence, reduce
thoughts and acts of SH. Commonly used antidepressants include
tricyclics and newer generation antidepressants (such as selective
serotonin reuptake inhibitors (SSRIs)). Tricyclic antidepressants
primarily inhibit both serotonin and norepinephrine reuptake,
whereas SSRIs specifically target synaptic serotonergic reuptake
(Feighner 1999). Given the link between serotonin activity, im-
pulsivity, and suicidal behaviour (van Heeringen 2014), both tri-
cyclic and SSRI antidepressants might be expected to be associated
with a serotonin-mediated reduction in impulsivity which could
reduce the likelihood that an individual will engage in SH. How-
ever, there have been significant concerns that SSRIs (apart from
fluoxetine) may increase suicidality in young people, resulting in
warnings from regulatory agencies in both the UK (Medicines and
Healthcare products Regulatory Agency; MHRA 2003) and the
USA (Food and Drug Administration 2004). Guidance from the
National Institute for Clinical Excellence (NICE) suggests that
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only fluoxetine has been shown to be of benefit for depression in
children and young people (NICE 2005). Recent studies, how-
ever, indicate that warnings from regulatory agenciesmay have had
unintended consequences, such as increases in suicide attempts
among young people (Lu 2014).
Antipsychotics
One risk factor for SH, including repetition of the behaviour, may
be heightened arousal, especially in relation to stressful life events.
The rationale for the use of antipsychotics is that by reducing this
arousal, the urge to engage in SH may also be reduced. Case se-
ries data suggest some benefit for low potency second generation
antipsychotics (such as quetiapine) in reducing suicidality in ado-
lescents diagnosed with major depression (e.g., Good 2006).
Mood stabilisers (including antiepileptics)
Mood stabilisers may have specific benefits for children and ado-
lescents diagnosed with bipolar disorder or unipolar disorder, es-
pecially in terms of preventing recurrence of episodes of mood
disorder. It might therefore be anticipated that these drugs would
offer benefits in terms of reducing the risk of suicidal behaviour.
To date, however, such an effect has only been found for lithium
in adults (Cipriani 2013). Lithium may also reduce the risk of sui-
cidal behaviour via a serotonin-mediated reduction in impulsivity
and aggression. It is also possible that the long-term clinical moni-
toring that all patients prescribed lithium treatment must undergo
contributes to a reduction in SH (Cipriani 2013).
Other pharmacological agents
Benzodiazepines and other anxiolytics might be expected to re-
duce suicidal behaviour through their specific effects on anxiety
(Tyrer 2012). However, because of their GABAminergic effects,
benzodiazepines may also increase aggression and disinhibition
(Albrecht 2014). In adolescents, furthermore, case series data also
describe an increased risk of suicidality and SH in those prescribed
benzodiazepines (e.g., Kandemir 2008). Other pharmacological
agents, such as the N-Methyl-D-aspartate receptor antagonist ke-
tamine, may also have beneficial effects in patients with major de-
pression. However, it is presently unclear whether ketamine has
a specific antisuicidal effect, or rather whether its effectiveness is
due to a reduction in depressive symptomatology more generally
(Fond 2014).
Natural products
In adults, the main focus with regard to natural products and sui-
cidal behaviour has been on dietary supplementation of omega-3
fatty acids (fish oils; Tanskanen 2001). Omega-3 fatty acids have
been implicated in the neural network shown to correlate with the
lethality of recent suicidal behaviour (Mann 2013). Blood plasma
polyunsaturated fatty acid levels have also been implicated in the
serotonin-mediated link between low cholesterol and suicidal be-
haviour, suggesting that low omega-3 fatty acid levels may have a
negative impact on serotonin function (Sublette 2006). For those
in whom SH is impulsive, omega-3 supplementation may stimu-
late serotonin activity, thereby reducing the likelihood of engaging
in SH (Brunner 2002).
Why it is important to do this review
SH in adolescents is a major social and healthcare problem. It
represents significant morbidity, is often repeated, and has strong
links to suicide. It also leads to substantial healthcare costs (Sinclair
2011). Many countries now have suicide prevention strategies
(World Health Organization 2014); all include a focus on im-
proved management of patients presenting with SH because of
their greatly elevated suicide risk and high levels of psychopathol-
ogy and distress. The National Suicide Prevention Strategy for
England (HerMajesty’sGovernmentDepartment ofHealth 2012)
and the national suicide prevention strategy for the USA (Office
of the Surgeon General (US) 2012), for example, highlight ado-
lescent SH patients as a key high risk group for special attention.
In recent years there has been considerable focus on improving the
standards of general hospital care for SH patients. In 2014 in the
UK, the Royal College of Psychiatrists published a guideline on
services (including assessment and treatment) for young people
who engage in SH (Royal College of Psychiatrists 2014). In 2004,
NICE produced a guideline on SH which focused on its short-
term physical and psychological management (NCCMH 2004).
More recently it produced a second guideline focused particularly
on longer-term management (NICE 2011), using some interim
data from the present review as the evidence base on therapeutic
interventions. A similar guideline was produced in Australia and
New Zealand (Boyce 2003). We had previously conducted a sys-
tematic review of treatment interventions for SH patients of all
ages in terms of reducing repetition of SH which had highlighted
the paucity of evidence for effective treatments, at least in terms
of this outcome (Hawton 1998; Hawton 1999). The first NICE
guideline essentially reinforced this conclusion (NCCMH 2004).
Using interim data from the present review, the second NICE
guideline concluded that there was no evidence showing that spe-
cific treatments for adolescent patients were more effective than
routine care (NICE 2011).
We have now fully updated our original review in order to provide
contemporary evidence to guide clinical policy and practice. Be-
cause of the increasing number treatment types and the need for
a special focus on adolescents who engage in SH, we have divided
the original review into three reviews: the present review which
focuses on interventions for children and adolescents, a second
review on pharmacological interventions in adults, and a third re-
view on psychosocial interventions for adults. In the earlier review
we focused on repetition of SH and suicide as the main outcomes.
In this update we have now also included data on treatment ad-
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herence, depression, hopelessness, suicidal ideation, and problem-
solving.
O B J E C T I V E S
To identify all randomised controlled trials (RCTs) of psychosocial
or pharmacological interventions for SH in children and adoles-
cents (up to 18 years of age), and to conduct meta-analyses (where
possible) to compare the effects of specific treatments with com-
parison types of care (such as treatment as usual, routine psychi-
atric care, enhanced usual care, placebo, or alternative pharmaco-
logical treatment) for children and adolescents who SH.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs, including cluster randomised and cross-over
trials, of specific psychosocial or pharmacological treatments ver-
sus treatment as usual, routine psychiatric care, enhanced usual
care, placebo, or any other pharmacological comparison in the
treatment of child and adolescent SH patients.
Types of participants
Participant characteristics
Participants were males and females up to 18 years of age of all
ethnicities. We also included trials where there was a small mi-
nority (<15%) of adult participants, providing these participants
had been referred to child and adolescent mental health services.
However, we undertook sensitivity analyses to assess the effect of
inclusion of such trials.
Diagnosis
Participants who had engaged in any type of non-fatal intentional
self-poisoning or self-injury resulting in presentation to child and
adolescent mental health services in the six months prior to trial
entry were included. There were no restrictions on the frequency
with which patients engaged in SH; thus, for example, we included
studies where participants had frequently repeated SH (for exam-
ple, those with SH behaviour associated with emergent borderline
personality disorder).
We defined SH as any intentional act of self-poisoning or self-
injury, irrespective of degree of suicidal intent or other types of
motivation. Thus it includes acts intended to result in death (‘at-
tempted suicide’), those without suicidal intent (for example, to
communicate distress or temporarily reduce unpleasant feelings),
and those with mixed motivation. Self-poisoning includes both
overdoses of medicinal drugs and ingestion of substances not in-
tended for consumption (such as pesticides). Self-injury includes
acts such as self-cutting, self-mutilation, attempted hanging, and
jumping in front ofmoving vehicles.We only included trials where
participants presented to clinical services as a result of SH.
Co-morbidities
There were no restrictions in terms of whether or not patients had
psychiatric disorders, or the nature of those disorders, with the
exception of intellectual disability (where any SH behaviour, such
as head-banging, is likely to be repetitive, as the purpose of this
behaviour is usually different from that involved in SH; NICE
2004).
Setting
Interventions delivered in inpatient or outpatient settings were
eligible for inclusion, as were trials from any country.
Subset data
We did not include trials in which only some participants had
engaged in SH or studies of people with psychiatric disorders in
which SH was an outcome variable but was not an inclusion cri-
terion for entry into the trial.
Types of interventions
Categorisation of the interventions included in this review was
informed by the trials themselves and was based on consensus dis-
cussions among the review teamwho have considerable experience
in both research and clinical practice related to SH.
Psychosocial interventions
Experimental interventions
This could include:
1. individual CBT-based psychotherapy;
2. interventions for patients with multiple episodes of SH or
emerging personality problems;
3. group-based psychotherapy;
4. enhanced assessment approaches;
5. compliance enhancement approaches;
6. home-based family interventions;
7. remote contact interventions.
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Comparator interventions
As treatment as usual (TAU) is likely to vary widely between set-
tings, following previous work we defined TAU as routine clinical
service provision that the patient would receive had they not been
included in the study (i.e., routine care or ’standard disposition’;
Hunt 2013). Other routine management comparators could in-
clude no specific treatment or enhanced usual care which refers to
TAU that has in someway been supplemented, such as through the
provision of psychoeducation, assertive outreach or more regular
contact with case managers, and standard assessment approaches.
Pharmacological interventions
Experimental interventions
This could include:
1. tricyclic antidepressants (TADs; e.g., amitriptyline);
2. newer generation antidepressants (NGAs) such as SSRIs
(e.g., fluoxetine), serotonin and noradrenaline reuptake
inhibitors (SNRIs; e.g., venlafaxine), norepinephrine reuptake
inhibitors (NRIs; e.g., reboxetine), tetracyclic antidepressants
(e.g., maprotiline), noradrenergic specific serotonergic
antidepressants (NaSSAs; e.g., mirtazapine), serotonin antagonist
or reuptake inhibitors (SARIs; e.g., trazodone), or reversible
inhibitors of monoamine oxidase type A (RIMAs; e.g.,
moclobemide)
3. any other antidepressants such as irreversible monoamine
oxidase inhibitors (MAOIs; e.g., bupropion);
4. antipsychotics (e.g., quetiapine);
5. mood stabilisers, including antiepileptics (e.g., sodium
valporate) and lithium;
6. other pharmacological agents (e.g., benzodiazepines,
ketamine);
7. natural products (e.g., omega-3 essential fatty acid
supplementation).
Comparator interventions
In pharmacological trials, where a comparison with the specific
effects of a drug is beingmade, the comparator is typically placebo,
which consists of any pharmacologically inactive treatment such
as sugar pills or injections with saline, although in some trials an-
other comparator pharmacological intervention (such as another
standard pharmacological agent or reduced dose of the interven-
tion agent) may be used.
Types of outcome measures
Primary outcomes
The primary outcomemeasure in this reviewwas the occurrence of
repeated SH (defined above) over a maximum follow-up period of
two years. Repetition was identified through self-report, collateral
report, clinical records, or research monitoring systems. As we
wished to incorporate themaximal amount of data from each trial,
we included both self-reported and hospital records of SH where
available. We report both proportions of participants repeating
SH and frequency of repeat episodes.
Secondary outcomes
1. Treatment adherence
Thiswas assessed using a range ofmeasures of adherence, including
pill counts, changes in blood measures, and the proportion of
participants that both started and completed treatment.
2. Depression
This was assessed either continuously, as scores on psychometric
measures of depression symptoms (for example total scores on the
Beck Depression Inventory (BDI; Beck 1961) or scores on the
depression sub-scale of the Hospital Anxiety and Depression Scale
(HADS; Zigmond 1983)), or dichotomously as the proportion of
patients reaching defined diagnostic criteria for depression.
3. Hopelessness
This was assessed as scores on psychometric measures of hope-
lessness, for example, total scores on the Beck Hopelessness Scale
(BHS; Beck 1974).
4. Suicidal ideation
This was assessed either continuously, as scores on psychometric
measures of suicidal ideation (for example, total scores on the Beck
Scale for Suicidal Ideation (BSS; Beck 1988)), or dichotomously, as
the proportion of patients reaching a defined cut-off for ideation.
5. Problem-solving
This was assessed either continuously, as scores on a psychometric
measure of problem-solving ability (for example total scores on
the Problem Solving Inventory (PSI; Heppner 1988)), or dichoto-
mously, as the proportion of patients with improved problems.
6. Suicide
This included both register-recorded deaths and reports from col-
lateral informants such as family members or neighbours.
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Timing of outcome assessment
We have reported outcomes for the following time periods.
1. At the conclusion of the treatment period.
2. Between zero and six months after the conclusion of the
treatment period.
3. Between six and 12 months after the conclusion of the
treatment period.
4. Between 12 and 24 months after the conclusion of the
treatment period.
Where there was more than one outcome assessment within a time
period, we only used data from the last assessment in the time
period, unless different outcomes were assessed at different points.
For treatment adherence, we also used within-treatment period
results.
Hierarchy of outcome measures
Where a trial measured the same outcome (for example, depres-
sion) in two or more ways, we used the most common measure
across trials in any meta-analysis, but we also reported scores from
the other measure in the text of the review.
Search methods for identification of studies
Electronic searches
The Cochrane Depression, Anxiety and Neurosis Review
Group’s Specialised Register (CCDANCTR)
The Cochrane Depression, Anxiety and Neurosis Group (CC-
DAN) maintains two clinical trials registers at their editorial base
in Bristol, UK: a references register and a studies-based register.
The CCDANCTR-References contains over 37,500 reports of
RCTs on depression, anxiety, and neurosis. Approximately 60% of
these references have been tagged to individual, coded trials. The
coded trials are held in the CCDANCTR-Studies and records are
linked between the two registers through the use of unique study
ID tags. Coding of trials is based on the EU-Psi coding manual.
Please contact the CCDAN Trials Search Coordinator for further
details.
Reports of trials for inclusion in the group’s registers are collated
from weekly generic searches of MEDLINE (1950 to date), EM-
BASE (1974 to date), and PsycINFO (1967 to date), as well as
quarterly searches of the Cochrane Central Register of Controlled
Trials (CENTRAL).
The CCDANCTR (Studies and References) was searched on 30
January 2015 using terms for self-harm (condition only), as out-
lined in Appendix 1. No restrictions on date, language, or publi-
cation status were applied to the search.
Additional electronic database searches
Complementary searches of MEDLINE (1998 to 2013), EM-
BASE (1998 to 2013), PsycINFO (1998 to 2013), and CEN-
TRAL (The Cochrane Library, Issue 10, 2013) were conducted
by Sarah Stockton, librarian at the University of Oxford, fol-
lowing the search strategy outlined in Appendix 2. Additionally,
KW searched the Australian Suicide Prevention RCT Database
(Christensen 2014). KW also conducted electronic searches of
ClinicalTrials.gov and the ISRCTN registry using the keywords
random* AND suicide attempt* OR self$harm* to identify relevant
ongoing trials.
Both the original version of this review and an unpublished ver-
sion also incorporated searches of the following databases: SIGLE
(1980 to March 2005) and Sociofile (1963 to July 2006).
Searching other resources
Hand searching
For the original version of this review, the authors hand searched
ten specialist journals within the fields of psychology and psychia-
try, including all English language suicidology journals as outlined
in Appendix 3. As these journals are now indexed in major elec-
tronic databases, we did not repeat hand searching for this update
of the review.
Reference lists
The reference lists of all relevant papers known to the investigators
were checked, as were the reference lists of major reviews which
included a focus on interventions for SH in children and ado-
lescents (Brausch 2012; Brent 2013; Burns 2000; Daniel 2009;
Gould 2003; Hawton 2012a; Newton 2010; Nock 2007; Ougrin
2011b; Ougrin 2015; Robinson 2011).
Correspondence
We consulted the authors of trials and other experts in the field of
suicidal behaviour to find out if they were aware of any ongoing
or unpublished RCTs concerning the treatment of adolescent SH
patients.
Data collection and analysis
For details of the data collection and analysis methods used in the
original version of this review see Appendix 4.
Selection of studies
For this update of the review, all authors independently assessed
the titles of trials identified by the systematic search for eligibility.
We made a distinction between:
1. eligible trials, in which any psychosocial or
psychopharmacological treatment was compared with a control
(treatment as usual, standard or less intensive types of aftercare,
placebo medication, or comparator drug/dose);
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2. ineligible general treatment trials (without any control
treatment).
All trials identified as potentially eligible for inclusion then un-
derwent a second screening. Pairs of review authors, working in-
dependently from one another, screened the full text of relevant
trials to identify whether the trial met our inclusion criteria.
Disagreements were resolved following consultation with KH.
Where disagreements could not be resolved from the information
reported within the trial, or where it was unclear whether the trial
satisfied our inclusion criteria, we contacted study authors to pro-
vide additional clarification.
Data extraction and management
In the current update, data from included trials were extracted by
KW and one of either TTS, EA, DG, PH, ET, or KvH using a
standardised extraction form. Review authors extracted data inde-
pendently of one another. Where there were any disagreements,
these were resolved through consensus discussions with KH.
Data extracted from each eligible trial included participant demo-
graphics, details of the treatment and control interventions, and
information on the outcome measures used to evaluate the effi-
cacy of the intervention. Study authors were contacted to provide
raw data for outcomes that were not reported in the full text of
included trials.
Both dichotomous and continuous outcome data were extracted
from eligible trials. As the use of non-validated psychometric scales
is associated with bias, we extracted continuous data only if the
psychometric scale used to measure the outcome of interest had
been previously published in a peer-reviewed journal (Marshall
2000), and was not subjected to item, scoring, or other modifica-
tion by the trial authors.
We planned the following main comparisons.
1. Individual CBT-based psychotherapy (e.g., CBT, PST)
versus TAU or other routine management.
2. Interventions for patients with multiple episodes of SH or
emerging personality problems versus TAU or other routine
management.
3. Group-based psychotherapy versus TAU or other routine
management.
4. Enhanced assessment approaches versus TAU or other
routine management.
5. Compliance enhancement approaches versus TAU or other
routine management.
6. Home-based family interventions versus TAU or other
routine management.
7. Remote contact interventions versus TAU or other routine
management.
8. Tricyclic antidepressants versus placebo or other
comparator drug/dose.
9. Newer generation antidepressants versus placebo or other
comparator drug/dose.
10. Any other antidepressants versus placebo or other
comparator drug/dose.
11. Antipsychotics versus placebo or other comparator drug/
dose.
12. Mood stabilisers versus placebo or other comparator drug/
dose.
13. Other pharmacological agents versus placebo or other
comparator drug/dose.
14. Natural products versus placebo or other comparator drug/
dose.
Assessment of risk of bias in included studies
Given that highly biased studies are more likely to overestimate
treatment effectiveness (Moher 1998), the quality of included
studies was evaluated independently by KW and one of either
TTS, EA, DG, PH, ET, or KvH using the criteria described in
Higgins 2011. This tool encourages consideration of the following
domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other bias.
Each source of potential bias was judged as contributing to at
“low,” “high,” or “unclear” risk of each potential bias indepen-
dently by two reviewers.Where inadequate details of the randomi-
sation, blinding, or outcome assessment procedures were provided
in the original report, we contacted authors to provide clarifica-
tion. Disagreements were resolved following discussion with KH.
Risk of bias for each included trial is reported in the text of the
review, as well as in the ’Risk of bias’ tables, along with supporting
quotations from the trial report to justify each judgment.
Measures of treatment effect
Dichotomous outcomes
We summarised dichotomous outcomes, such as the number of
participants engaging in a repeat SH episode and deaths by sui-
cide, using the summary odds ratios (OR) and the accompanying
95% confidence interval (CI), as the OR is the most appropriate
effect size statistic for summarising associations between two di-
chotomous groups (Fleiss 1994).
Continuous outcomes
For outcomes measured on a continuous scale, we used mean dif-
ferences (MD) and accompanying 95% CI where the same out-
come measure was employed. Where different outcome measures
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were employed, we used the standardised mean difference (SMD)
and its accompanying 95% CI.
Trials were aggregated for the purposes of meta-analysis only if
treatments were sufficiently similar. For trials that could not be
included in a meta-analysis, we have instead provided narrative
descriptions of the results.
Unit of analysis issues
Zelen design trials
Trials in this area are increasingly employing Zelen’s method in
which consent is obtained subsequent to randomisation and treat-
ment allocation. This design may lead to bias if, for example, par-
ticipants allocated to one particular arm of the trial disproportion-
ally refuse to provide consent for participation or, alternatively,
if participants only provide consent provided they are allowed to
cross-over to the active treatment arm (Torgerson 2004). No trial
included in this review used Zelen’s design. Given the uncertainty
of whether to use data based on those randomised or those con-
senting to participation, should a trial using Zelen’s method be
identified in future updates of this review we plan to extract data
using both sources where possible. We also plan to conduct sensi-
tivity analyses to investigate what impact, if any, the inclusion of
these trials may have on the pooled estimate of treatment effect.
Cluster randomised trials
Cluster randomisation, for example by clinician or practice, can
lead to overestimation of the significance of a treatment effect,
resulting in an inflation of the nominal type I error rate, unless ap-
propriate adjustment is made for the effects of clustering (Donner
2002; Kerry 1998). One trial included in the review used cluster-
ing (Ougrin 2011a). As the study authors were unable to provide
us with the values of either the inter-cluster correlation coefficient
or the design effect to enable us to statistically account for the
effects of clustering (as per the guidance in Higgins 2011), for this
trial we have used unadjusted data, but have commented on the
impact this may have had on the results observed in the text of the
review.
In future updates of this review, should we be able to obtain in-
formation on either the inter-cluster correlation coefficient or the
design effect, we will use the formula given in Higgins 2011 to
account for the effects of clustering.
Cross-over trials
A primary concern with cross-over trials is the “carry-over” effect
in which the effect of the intervention treatment (pharmacologi-
cal, physiological, or psychological) influences the participant’s re-
sponse to the subsequent control condition (Elbourne 2002). As a
consequence, on entry to the second phase of the trial, participants
may differ systematically from their initial state despite a wash-out
phase. This, in turn, may result in a concomitant underestimation
of the effectiveness of the treatment intervention (Curtin 2002a;
Curtin 2002b). No trials in the current review included cross-over
methodology. However, should we identify any such trials in fu-
ture updates, only data from the first phase of the study, prior to
cross-over, will be included to protect against the carry-over effect.
Studies with multiple treatment groups
No trials in the current review includedmultiple treatment groups.
In future updates, however, should trials with multiple treatment
groups be identified, all relevant treatment arms will be included
in the review. For binary data we will combine data or use the data
from the comparison arm in two or more analyses as appropriate.
For continuous data, we will combine data following the formula
given in Higgins 2011, section 7.7.3.8.
Studies with adjusted effect sizes
None of the trials included in the current update provided adjusted
effect sizes. In future updates, however, where trials reported both
unadjusted and adjusted effect sizes, we will include only unad-
justed effect sizes.
Dealing with missing data
Wedid not impute missing data as we considered that the bias that
would be introduced by doing this would have outweighed any
benefit (in terms of increased statistical power) that may have been
gained by the inclusion of imputed data. However, where authors
omitted standard deviations (SD) for continuous measures, we
planned to estimate these using themethoddescribed inTownsend
2001.
Dichotomous data
Although some authors said they conducted intention-to-treat
analyses, few presented such analyses as defined by Higgins 2011.
Therefore, outcome analyses for both dichotomous and contin-
uous data were based on all information available on study par-
ticipants. For dichotomous outcomes, we included data on only
those participants whose results were known, using as the denom-
inator the total number of participants with data for the particular
outcome of interest, as recommended (Higgins 2011).
Continuous data
For continuous outcomes, we have included data only on observed
cases.
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Missing data
Where data on outcomes of interest were incomplete or were ex-
cluded from the text of the trial, we contacted study authors in
order to try to obtain further information.
Assessment of heterogeneity
Between-study heterogeneity can be assessed using either the Chi2
or I2 statistics. In this review, however, we used only the I2 statistic
to determine heterogeneity as this is considered to be more reli-
able (Higgins 2011). The I2 statistic indicates the percentage of
between-study variation due to chance (Higgins 2011), and can
take any value from 0% to 100%. We used the following val-
ues to denote relative importance of heterogeneity: 0% to 40%
(unimportant), 30% to 60% (moderate), 50% to 90% (substan-
tial), and 75% to 100% (considerable), as per the guidance in the
Cochrane Handbook(Higgins 2011).Where we found substantial
levels of heterogeneity (i.e., ≥ 75%), we explored reasons for this
heterogeneity. We also planned to investigate heterogeneity when
the I2 statistic was lower than 75% where either the direction or
magnitude of a trial effect size was clearly discrepant from that of
other trials included in the meta-analysis (see Subgroup analysis
and investigation of heterogeneity for further information on these
analyses).
Assessment of reporting biases
Reporting bias occurs when the decision to publish a particu-
lar trial is influenced by the direction and significance of its re-
sults (Egger 1997). Research suggests, for example, that trials with
statistically significant findings are more likely to be submitted
for publication and to subsequently be accepted for publication
(Hopewell 2009), leading to possible overestimation of the true
treatment effect. To assess whether trials included in any meta-
analysis were affected by reporting bias, we planned to enter data
into a funnel plot when a meta-analysis included results of at least
ten trials. Should evidence of any small study effects be identified,
we planned to explore reasons for funnel plot asymmetry, includ-
ing the presence of publication bias (Egger 1997).
Data synthesis
For the purposes of meta-analysis, we calculated the pooled OR
and accompanying 95%CI using the random-effects model as this
is the most appropriate model for incorporating heterogeneity be-
tween studies (Higgins 2011). Specifically, for dichotomous data,
the Mantel-Haenszel method was used, whilst the inverted vari-
ancemethodwas used for continuous data. However, a fixed-effect
analysis was also undertaken to investigate the potential effect of
method choice on the estimates of treatment effect. Any material
differences in ORs between these two methods are reported de-
scriptively in the text of the review. All analyses were undertaken
in RevMan, version 5.3 (RevMan 2014).
Subgroup analysis and investigation of heterogeneity
Subgroup analyses
In the original version of this review, we planned to undertake sub-
group analyses by repeater status and gender but found there were
insufficient data. Consequently, in this update we only undertook
a priori subgroup analyses by gender or repeater status where there
were sufficient data to do so.
Given the increasinguse of enhancedusual care rather thanTAU in
trials in this area, we also planned to undertake sub-group analyses
to determine whether comparator choice influenced the pattern
of results observed.
Investigation of heterogeneity
We planned that should any meta-analysis be associated with sub-
stantial levels of between-study heterogeneity (i.e., I2≥ 75%), KH
and KW would independently triple-check data to ensure these
had been correctly entered. Assuming data had been entered cor-
rectly, we would investigate the source of this heterogeneity by
visually inspecting the forest plot and removing each trial which
has a very different result to the general pattern of the others until
homogeneity was restored as indicted by an I2 statistic < 75%. We
planned to report the results of this sensitivity analysis in the text
of the review alongside hypotheses regarding the likely causes of
the heterogeneity.
Sensitivity analysis
We planned to undertake sensitivity analyses, where appropriate,
as outlined below.
1. Where a trial made use of Zelen’s method of randomisation
(see Unit of analysis issues section).
2. Where a trial contributed to substantial between-study
heterogeneity (see Subgroup analysis and investigation of
heterogeneity section).
3. Where a trial included a mixture of both adolescent and
adult participants.
’Summary of findings’ table
A ’Summary of findings’ table was prepared for the primary out-
comemeasure, repetition of SH, following recommendations out-
lined in Schünemann 2008a, section 11.5. This table provides in-
formation concerning the overall quality of evidence from each
included trial. The ’Summary of findings’ table was prepared using
GRADEpro software (GRADEpro). Quality of the evidence was
assessed following recommendations in the Cochrane Handbook
(Higgins 2011).
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Description of studies
Results of the search
For this update, a total of 23,763 citations were found using the
search strategies outlined inAppendix 1 andAppendix 2. A further
10 trials were identified through correspondence with researchers
in the field; these trials were ongoing at the time of the systematic
search. All but one have subsequently been published and a report
on the remaining trial is currently in preparation. We were able
to include data for this unpublished trial, however, by correspon-
dence with and permission from study authors. In consultation
with CCDAN, we have divided the original review into three sep-
arate reviews: the present review which focuses on psychosocial
or pharmacological interventions for children and adolescents, a
second review on psychosocial interventions for adults, and the
third on pharmacological interventions for adults. All but one of
the 10 additional trials identified through correspondence with
study authors have evaluated psychosocial interventions in adults
and these have therefore been included in the corresponding re-
view. The remaining trial is one of a psychosocial intervention for
children and adolescents (Cooney 2010) and has therefore been
included in the present review.
After deduplication, the overall figure for citations was reduced to
16,736. Of these, 16,491 were excluded after screening, whilst a
further 221 were excluded after reviewing the full texts (Figure 1).
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Figure 1. Prisma flow diagram
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Included studies
In the previous versions of this review (Hawton 1998; Hawton
1999;NICE 2011), six trials of psychosocial interventions for ado-
lescent SH patients were included (Cotgrove 1995; Donaldson
2005;Harrington 1998;Hazell 2009; Spirito 2002;Wood 2001a).
The present update includes information from an additional
five trials (Cooney 2010; Green 2011; Mehlum 2014; Ougrin
2011a; Rossouw 2012a). The present review therefore includes 11
non-overlapping trials. A further report (Ougrin 2013) provided
two-year follow-up data for one of the previously-included trials
(Ougrin 2011a).
None of the included trials were unpublished, however unpub-
lished data were obtained from study authors for eight of the 11
included trials (Cooney 2010; Cotgrove 1995; Donaldson 2005;
Green 2011; Ougrin 2011a; Rossouw 2012a; Spirito 2002; Wood
2001a).
Five ongoing trials of interventions for SH in children and adoles-
cents were also identified (see Characteristics of ongoing studies
for further information on these trials).
Design
Of the 11 trials, all were described as randomised controlled trials.
Most (k = 10) employed a simple randomisation procedure based
on individual allocation to the intervention and control groups.
In one trial, clinicians rather than participants were randomised
(Ougrin 2011a).
Participants
The included trials comprised a total of 1,126 child and adolescent
participants. All had engaged in at least one episode of SH in the
six months prior to randomisation.
Participant characteristics
Of the nine trials in which information on age was provided, the
average age of participants at randomisation was 15.3 years (SD
0.5). All participants had been referred to child and adolescent
mental health services. Of the 10 trials that recorded informa-
tion on gender, the majority of participants were female (80.6%),
reflecting the typical pattern for SH in children and adolescents
(Hawton 2008a).
Diagnosis
A history of SH prior to the index episode (i.e., multiple episodes
of SH) was a requirement for participation in five trials (Cooney
2010; Green 2011; Hazell 2009; Mehlum 2014; Wood 2001a).
In one trial, over half of the sample (58.6%) had a history of
multiple episodes of SH (Ougrin 2011a), whilst in a further trial
just under half of the sample (48.4%) had a history of multiple
episodes (Donaldson 2005). For four trials, information on the
proportion of participants with a history of SH prior to the in-
dex episode was not reported (Cotgrove 1995; Harrington 1998;
Rossouw 2012a; Spirito 2002). Two trials included participants
who had made a “suicide attempt” (i.e., with evidence of suici-
dal intent) (Donaldson 2005; Spirito 2002); however, most trials
(k = 7) included adolescents irrespective of intent (Cooney 2010;
Harrington 1998; Hazell 2009; Mehlum 2014; Ougrin 2011a;
Rossouw 2012a; Wood 2001a). In the two remaining trials, infor-
mation on intent was not reported (Cotgrove 1995; Green 2011).
Information on the method of SH for the index episode was not
reported in two trials (Cooney 2010; Mehlum 2014). In three
trials, information on methods used in all lifetime episodes of SH
(including the index episode) was reported (Hazell 2009; Rossouw
2012a;Wood 2001a). In the latter two trials, 64.0% and 94.4% re-
spectively had a history of self-poisoning whilst 95.5% and 74.6%
respectively had a history of self-injury. In Hazell 2009, 97.0%
had a history of self-cutting, 71.0% of head banging, 57.0% of
self-poisoningwith prescriptionmedication, 36.0% of self-smoth-
ering, 25.0% of self-strangulation, 19.0% of other forms of self-
injury, 19.0% of self-drowning, 17.0% of jumping from a height,
and 35.0% some other form of SH. Information on methods used
for the index episode only for the remaining six trials is presented
in Table 1. In these trials, the majority of participants (k = 6;
67.1%) had engaged in self-poisoning.
Co-morbidities
Information on current psychiatric diagnoses was reported in 10
trials (see Table 2). In these trials, the most common psychiatric
diagnoses were major depression (k = 8; mean 65.2%) and be-
havioural disorders (k = 4; mean 35.8%). One trial included a high
proportion of adolescents diagnosed as having features of emerg-
ing borderline personality disorder (72.5%; Rossouw 2012a).
Details on comorbid diagnoses were not reported in eight of the
11 trials (Cotgrove 1995; Green 2011; Harrington 1998; Hazell
2009; Mehlum 2014; Ougrin 2011a; Rossouw 2012a; Wood
2001a). In the remaining three trials, between 7.3% (Spirito 2002)
and 93.1% (Cooney 2010) of participants were diagnosed with
two or more psychiatric disorders. However, further information
on specific diagnoses was not provided.
Setting
Of the 11 non-overlapping RCTs included in this review,
five were from the UK (Cotgrove 1995; Green 2011; Ougrin
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2011a; Rossouw 2012a; Wood 2001a), three were from the US
(Donaldson 2005; Harrington 1998; Spirito 2002), and one was
from each of Australia (Hazell 2009), New Zealand (Cooney
2010), and Norway (Mehlum 2014). Although all participants
were identified following a clinical presentation for SH, treatment
was delivered on an outpatient basis or in the patient’s home in
nine trials. In the remaining trials of brief (one hour) compliance
enhancement (Spirito 2002) and therapeutic assessment (Ougrin
2011a), the intervention was delivered whilst the adolescent was
receiving treatment in hospital.
Interventions
All 11 trials included in this review investigated the effectiveness
of various forms of psychosocial therapy.
1. Individual CBT-based psychotherapy versus TAU
(Donaldson 2005).
2. Interventions for patients with multiple episodes of SH or
emerging personality problems versus TAU or other routine
management (i.e., enhanced usual care) (Cooney 2010; Mehlum
2014; Rossouw 2012a).
3. Group-based psychotherapy versus TAU (Green 2011;
Hazell 2009; Wood 2001a).
4. Therapeutic assessment versus TAU (i.e., standard
assessment) (Ougrin 2011a).
5. Compliance enhancement plus standard disposition
planning versus TAU (i.e., standard disposition) (Spirito 2002).
6. Home-based family intervention versus TAU (Harrington
1998).
7. Remote contact interventions plus TAU versus TAU
(Cotgrove 1995).
There were no trials in which pharmacological treatments were
investigated.
Outcomes
All 11 trials reported information on the primary outcome: repe-
tition of SH. In the majority of these trials (k = 8), this was based
on self-reported information (Cooney 2010; Donaldson 2005;
Harrington 1998; Hazell 2009; Mehlum 2014; Rossouw 2012a;
Spirito 2002; Wood 2001a), whilst in one further trial, self-re-
ported information was combined with information from a col-
lateral informant such as a parent (Green 2011). In one trial, in-
formation on repetition of SH was obtained from clinical or hos-
pital notes supplemented by information from general practition-
ers, social workers, and psychologists (where relevant) (Cotgrove
1995). In only one trial, information on repetition of SH was
based solely on representation to accident and emergency depart-
ments (Ougrin 2011a).
In the seven trials that recorded information on treatment adher-
ence, this was assessed using a variety of methods including: the
proportion of participants that completed the full course of treat-
ment (Donaldson 2005; Harrington 1998; Rossouw 2012a), the
proportion attending their first appointment (Ougrin 2011a), the
proportion attending at least one treatment session (Spirito 2002),
and the total number of treatment sessions attended (Cooney
2010; Mehlum 2014; Spirito 2002). Depression was assessed us-
ing the Mood and Feelings Questionnaire (MFQ; Angold 1995)
in five trials (Green 2011; Hazell 2009; Mehlum 2014; Rossouw
2012a; Wood 2001a), the Montgomery-Åsberg Depression Rat-
ing Scale (MADRS; Montgomery 1979) in one trial (Mehlum
2014), and theCenter for Epidemiologic Studies Depression Scale
(CES-D; Radloff 1991) in one trial (Donaldson 2005). Hope-
lessness was assessed using the Hopelessness Scale (HS; Kazdin
1986) in one trial (Harrington 1998), the BHS in a second trial
(Mehlum2014), and by the future optimism sub-scale score on the
Reasons for Living Inventory-Adolescent (RFL-A; Osman 1998),
which was reverse coded in the present review to indicate a per-
ceived lack of optimism about the future (Cooney 2010). In six tri-
als, information on suicidal ideation was assessed using the Suici-
dal Ideation Questionnaire (SIQ; Reynolds 1985; Reynolds 1988;
Reynolds 1999) whilst in a further trial (Cooney 2010) suicidal
ideation was assessed using the Beck Scale for Suicide Ideation
(Beck 1991). For the two trials that reported information on prob-
lem-solving, this was assessed using the Social Problem-Solving
Inventory (SPSI; Maydeu-Olivares 1996) and the Means Ends
Problem-Solving test (MEPS; Platt 1971) in one trial (Donaldson
2005) and by the Generation of Alternative Solutions subscale of
the SPSI in a second (Harrington 1998). Suicide was assessed us-
ing medical or health service records (Green 2011; Hazell 2009)
or via interviews with parents (Donaldson 2005). In the major-
ity of trials (k = 6), however, it was unclear how suicide was as-
sessed (Harrington 1998;Mehlum 2014; Ougrin 2011a; Rossouw
2012a; Spirito 2002; Wood 2001a).
Excluded studies
A total of 221 articles were excluded from this update: 94 were
excluded because not all patients engaged in SH, 63 used a non-
randomised clinical trial design, 28 were reviews, editorials, let-
ters to the editor, or conference proceedings that were not rele-
vant to the treatment of SH in children and adolescents, and 23
were trial protocols. In addition, 11 were excluded as SH could
have occurred at any time rather than within six months of ran-
domisation, and one each were excluded either because only data
from one trial arm was presented (however, a related publication
in which data for both the intervention and control arms were
presented was eligible for inclusion), or because the data reported
in the article was for a period beyond two years (however, articles
reporting data for earlier follow-up periods for this trial were eli-
gible for inclusion).
Details on the reasons for exclusion of 32 trials clearly related to
interventions for suicidality in children and adolescents can be
found in the Characteristics of excluded studies section.
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Ongoing studies
Five ongoing trials of psychosocial interventions for SH in chil-
dren and adolescents were identified. In these trials, the effec-
tiveness of the following treatments are being investigated: family
therapy (Asarnow 2014; Cottrell 2014; Diamond 2014), a crisis
card in conjunction with individualised psychotherapy (Fischer
2013), and combined individual and group sessions of DBT-A
(Linehan 2014). Full details of these studies are provided in the
Characteristics of ongoing studies.
Studies awaiting classification
There were no potentially eligible studies which have not been
incorporated into the review.
Risk of bias in included studies
Summaries of the overall risk of bias for the included studies are
presented in Figure 2 and Figure 3. Risk of bias for each included
study is also considered within the text of the review and in the
’Risk of bias’ tables.
Figure 2. Risk of bias graph: Review authors’ judgements for each risk of bias item presented as percentages
across all included studies.
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Figure 3. Risk of bias summary graph: Review authors’ judgements about each risk of bias item for each
included study.
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Sequence generation
Of the 11 independent trials included in this review, all used ran-
dom allocation. We rated the majority (k = 9; 81.8%) as having
a low risk of bias for this item. Four used a random numbers ta-
ble to allocate adolescents to the intervention and control groups
(Donaldson 2005; Hazell 2009; Spirito 2002; Wood 2001a),
three used permuted block randomisation (Mehlum 2014;Ougrin
2011a; Rossouw 2012a), one used a minimisation algorithm
(Green 2011), and one used a computerised randomisation se-
quence (Cooney 2010). We rated one trial as having an unclear
risk of bias for this item as although opaque, sealed envelopes were
used, it is unclear whether these were shuffled to ensure random
sequence generation (Harrington 1998).We rated one trial as hav-
ing a high risk of bias for this item as an open numbers table was
used (Cotgrove 1995).
Allocation concealment (selection bias)
We rated the majority of trials as having a low risk of bias for
allocation concealment (k = 8; 72.7%). Allocation was by an off-
site researcher in four trials (Green 2011; Hazell 2009; Mehlum
2014; Rossouw 2012a), by a third party researcher working in-
dependently of the trial team in one trial (Ougrin 2011a), and
by using opaque, sealed envelopes in two further trials (Cooney
2010; Harrington 1998). In one trial, “[t]reatment allocation was
concealed from the outcome assessors” (Wood 2001a, p.1247),
although details of the method used to conceal allocation were not
provided. We rated two trials as having an unclear risk of bias for
this item as no details on allocation concealment were provided
(Donaldson 2005; Spirito 2002), whilst we rated the remaining
trial as having a high risk of bias for this item as an open numbers
table was used (Cotgrove 1995).
Blinding (performance bias and detection bias)
We assessed blinding separately for participants, clinical personnel,
and outcome assessors.
Blinding of participants
Overall, we classified blinding of participants as resulting in a high
risk of bias for the majority of trials included in this review (k = 9;
81.8%), as psychosocial interventions predominated and we con-
tend that it is generally not possible to blind participants to psy-
chosocial therapy.We rated one trial as having a low risk of bias for
this item as it was reported that participants were blind to the treat-
ment allocation; however, further details on the method of achiev-
ing participant blinding were not reported (Rossouw 2012a). We
rated the remaining trial as having an unclear risk of bias for this
item as, although no information on participant blinding was pro-
vided, both treatments were so similar it remains possible that par-
ticipants may have been blind to treatment allocation (Donaldson
2005).
Blinding of personnel
Again, we classified blinding of clinical personnel as resulting in a
high risk of bias for the majority of trials included in this review
(k = 10; 90.9%), as we contend that it is not possible to blind
clinicians to the psychosocial therapy they are delivering.We rated
one trial, however, as having an unclear risk of bias for this item as,
although no information on personnel blinding was reported, the
intervention consisted of a one-off emergency card which could
have been given to participants in private (Cotgrove 1995).
Blinding of outcome assessors
As outcome assessors were blind to treatment allocation in eight
trials (72.7%), we rated this item as having a low risk of bias for
themajority of trials. We rated the remaining three trials, however,
as having an unclear risk of bias for this item as no information
on blinding of outcome assessors was provided (Cotgrove 1995;
Donaldson 2005; Spirito 2002).
Incomplete outcome data (attrition bias)
For four trials, the authors reported having conducted analyses on
an intention-to-treat basis we therefore classified them as having
a low risk of bias for this item (36.4%); although the methods
used to conduct these analyses were not clear (Donaldson 2005;
Harrington 1998; Mehlum 2014; Wood 2001a). Although the
authors of one trial undertook per protocol analyses (Cooney
2010), as there was a 0% drop-out rate we nevertheless rated it
as having a low risk of bias for this item. Two trials used the
last observation carried forward method (Hazell 2009; Ougrin
2011a), which we understand may introduce bias (Engles 2003).
We therefore rated these trials as having an unclear risk of bias
for this item. We also rated three additional trials as having an
unclear risk of bias for this item as there were insufficient details
to confirm whether intention-to-treat or per protocol analyses had
been undertaken (Green 2011; Rossouw 2012a; Spirito 2002).
We rated one trial as having a high risk of bias for this item as
around one-fifth of the consecutive admissions during this period
were not included in the trial and the reasons for excluding these
participants were not clearly stated.
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Selective reporting (reporting bias)
As we did not have access to trial protocols for the trials included
in this review, it is difficult to assess the degree to which selective
outcome reporting could have occurred. Consequently, we rated
all 11 trials as having an unclear risk of bias for this item.
Other potential sources of bias
We classified most trials as having a low risk of bias for this item
as no evidence of other bias was apparent (k = 9; 81.8%). In
one trial, however, some participants randomised to the control
groupmistakenly received the intervention treatment and yet were
included in the control group for all subsequent analyses (Cotgrove
1995), whilst in another there was the potential for contamination
as therapists delivered both the intervention and control therapy
(Donaldson 2005). We therefore classified both of these trials as
having a high risk of bias for this item.
The source of funding was not indicated in three trials (Cooney
2010; Cotgrove 1995; Rossouw 2012a). For the remaining trials,
funding was received from a variety of sources, including: govern-
ment (Harrington 1998), health promotion foundations (Wood
2001a), joint university and suicide prevention or health promo-
tion foundations (Donaldson 2005; Green 2011), joint charita-
ble and research foundations (Ougrin 2011a), and a combina-
tion of government, university, and health promotion foundations
(Mehlum 2014; Spirito 2002). For one, no specific funding was
received for the trial (Hazell 2009).
Effects of interventions
See:Summaryoffindings for themain comparisonComparison
1: individual CBT-based psychotherapy versus treatment as usual;
Summary of findings 2Comparison 2: interventions for patients
with multiple episodes of SH or emerging personality problems
versus treatment as usual or routine management; Summary
of findings 3 Comparison 5: group-based psychotherapy versus
treatment as usual; Summary of findings 4 Comparison 6:
therapeutic assessment versus treatment as usual (i.e., standard
assessment); Summary of findings 5 Comparison 7: compliance
enhancement plus treatment as usual (i.e., standard disposition
planning) versus treatment as usual; Summary of findings 6
Comparison 8: home-based family intervention versus treatment
as usual; Summary of findings 7 Comparison 9: remote contact
interventions versus treatment as usual
As only two interventions, DBT-A and group-based therapy, were
evaluated in more than one independent trial, meta-analyses were
only undertaken for these two interventions. We have reported all
other interventions, which were evaluated in only single trials, in
the text.
There were no trials of pharmacological agents.
Comparison 1: Individual CBT-based psychotherapy
versus TAU
The effectiveness of brief (i.e., up to 10 sessions) skills-based psy-
chological therapy (mainly involving training in problem-solving
and affect management) versus supportive relationship therapy,
which was designed to be as close as possible to usual care for
this population, was assessed in one small study of 12 to 17 year
olds presenting to paediatric general or psychiatric facilities fol-
lowing self-injury in which an intent to die was indicated (N =
39; Donaldson 2005).
Primary outcome
1.1 Repetition of SH
There was no evidence of a significant treatment effect for brief
psychological therapy on repetition of SH during the six month
follow-up period (4/21 versus 2/18; OR 1.88, 95% CI 0.30 to
11.73; k = 1; N = 39). The evidence contributing to this out-
come was of moderate quality according to the GRADE criteria
(Summary of findings for the main comparison).
Secondary outcomes
1.2 Treatment adherence
There was no evidence of a significant treatment effect on the pro-
portion of participants who completed the full course of treatment
(13/21 versus 13/18; OR 0.63, 95% CI 0.16 to 2.43; k = 1; N =
39).
Data on the number of treatment sessions attended was only avail-
able for those who completed the three and six month follow-
up assessments. There was no evidence of a significant treatment
effect on the number of sessions attended (mean 9.70, SD 2.40,
n = 15 versus mean 9.50, SD 1.30, n = 16; MD 0.20, 95% CI -
1.17 to 1.57; k = 1; N = 31).
1.3 Depression
There was no evidence of a significant treatment effect of brief
psychological therapy on depression scores at six months (mean
10.92, SD 15.21, n = 15 versus mean 16.81, SD 15.10, n = 16;
MD -5.89, 95% CI -16.57 to 4.79; k = 1; N = 31) or 12 months
(mean 10.33, SD 11.45, n = 15 versus mean 13.89, SD 8.28, n =
15; MD -3.56, 95%CI -10.71 to 3.59; k = 1; N = 30).
1.4 Hopelessness
There were no data available for this outcome.
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1.5 Suicidal ideation
There was also no evidence of a significant treatment effect on
suicidal ideation scores at six months (mean 27.08, SD 39.82, n
= 15 versus mean 32.19, SD 30.45, n = 15; MD -5.11, 95% CI
-30.48 to 20.26; k = 1; N = 30) or 12 months (mean 24.89, SD
28.52, n = 15 versus mean 33.33, SD 30.42, n = 15; MD -8.44,
95% CI -29.54 to 12.66; k = 1; N = 30).
1.6 Problem-solving
Similarly, no clear evidence of a significant treatment effect was
found for problem-solving scores according to either the SPSI or
MEPS at the six month follow up assessment (SPSI: mean 126.69,
SD 39.92, n = 15 versus mean 108.81, SD 31.00, n = 15; MD
17.88, 95% CI -7.70 to 43.46; k = 1; N = 30; MEPS: mean
7.00, SD 4.24, n = 15 versus mean 7.56, SD 3.41, n = 15; MD -
0.56, 95% CI -3.31 to 2.19; k = 1; N = 30). However, by the 12
month assessment there was evidence of a significant treatment
effect of psychological therapy according to scores on the SPSI
(mean 139.00, SD 31.39, n = 15 versus mean 105.00, SD 29.48,
n = 15; MD 34.00, 95% CI 12.21 to 55.79; k = 1; N = 30) but
not on the MEPS (mean 9.44, SD 4.72, n = 15 versus mean 9.89,
SD 2.47, n = 15; MD -0.45, 95% CI -3.15 to 2.25; k = 1; N =
30).
1.7 Suicide
No participants died by suicide in either arm during the 12month
follow-up period.
Comparison 2: interventions for patients with
multiple episodes of SH or emerging personality
problems versus TAU or other routine management
Dialectical behaviour therapy for adolescents (DBT-A)
Two trials evaluated the effectiveness of a dialectical behaviour
therapy program specially adapted for adolescents, comprising in-
dividual, group-based, and family therapy sessions, in adolescents
(between 12 and 19 years) with a history of multiple episodes of
SH (Cooney 2010; N = 29; Mehlum 2014; N = 77). The com-
parator was TAU in Cooney 2010 and enhanced usual care in
Mehlum 2014.
Primary outcome
2.1 Repetition of SH
There was no evidence of a significant treatment effect of DBT-
A at the post-intervention assessment when compared to either
TAU or enhanced usual care (Analysis 1.1; k = 2; N = 105). There
was also no evidence of a significant difference based on which
comparator condition DBT-A was compared against (i.e., TAU
or enhanced usual care; test for subgroup differences: Chi² = 1.70;
df = 1; p = 0.19; I² = 41.0%).
With respect to frequency of SH episodes, there was no evidence
of a treatment effect ofDBT-A at the post-intervention assessment
(Analysis 1.2; k = 2; N = 104). Once again, there was no evidence
of a significant difference based on the comparator condition (i.e.,
TAU or enhanced usual care; test for subgroup differences: Chi²
= 2.86; df = 1; p = 0.09; I² = 65.1%). The quality of evidence for
both outcomes was low (Summary of findings 2).
The study authors of one of these trials measured longitudinal
changes in frequency of SH over a 15 week period, based on com-
parisons of assessments “from baseline to week 9 and from week
10 to week 15,” and reported that “[t]he average drop on loga-
rithmic scale in self-harm frequency in the DBT-A group (slope
-1.28, 95% CI -1.77 to -0.80, P < 0.001) was highly significant,
whereas the drop in the [enhanced usual care] group (slope -0.36,
95% CI -0.99 to 0.26, P = 0.254) was not. The between-group
difference was statistically significant (1 slope = -0.92, 95% CI -
1.69 to -0.15, P = 0.021)” (Mehlum 2014, p.7).
Secondary outcomes
2.2 Treatment adherence
Although adolescents randomised to the DBT-A treatment group
attended a greater number of individual therapy sessions, there
was no evidence of a significant treatment effect (Analysis 1.3;
k = 2; N = 106). However, there was evidence of a significant
treatment effect based on comparator condition (i.e., TAU versus
enhanced usual care; Analysis 1.3; test for subgroup differences:
Chi² = 30.01; df = 1; P < 0.001; I² = 96%). Compared against
TAU, participants randomised to DBT-A attended a significantly
greater number of individual therapy sessions (MD 16.10, 95%
CI 12.16 to 20.04; k = 1; N = 29).
There was no evidence that adolescents randomised to the DBT-
A group attended a significantly greater number of family therapy
sessions overall (Analysis 1.4; k = 2; N = 106). Once again, how-
ever, there was evidence of a significant difference by compara-
tor condition (Analysis 1.4; test for subgroup differences: Chi² =
16.14; df = 1; P < 0.001; I² 93.8%). Compared against TAU, par-
ticipants randomised to DBT-A attended a significantly greater
number of family therapy sessions (MD 4.90, 95% CI 2.57 to
7.23; k = 1; N = 29).
Participants in the DBT-A group in Mehlum 2014 attended sig-
nificantly more group sessions compared to those in the enhanced
usual care group (mean 11.2, SD 5.9, n = 39 versus mean 0.50,
SD 2.10, n = 38; MD 10.70, 95% CI 8.73 to 12.67; k = 1; N =
77). As adolescents randomised to TAU in Cooney 2010 were not
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required to attend group therapy sessions, it was not possible to
assess the effectiveness of DBT-A in this trial with respect to this
outcome.
There was no evidence of a significant treatment effect for the
number of medication review meetings attended in Cooney 2010
(mean 2.40, SD 2.20, n = 14 versus mean 1.60, SD 2.90, n = 15;
MD 0.80, 95% CI -1.07 to 2.67; k = 1; N = 29) or for the number
of telephone contacts received in Mehlum 2014 (mean 3.30, SD
4.50, n = 39 versus mean 3.50, SD 4.40, n = 38; MD -0.20, 95%
CI -2.19 to 1.79; k = 1; N = 77).
2.3 Depression
No data on depression scores were reported in Cooney 2010.
In Mehlum 2014, depression was measured in two ways: as scores
on the depression sub-scale of the MFQ and as total scores on the
MADRS. There was no clear evidence of a difference in treatment
effect forDBT-A according to eithermeasure at the post-treatment
assessment (MFQ:Analysis 1.6;MD -2.39, 95%CI -5.02 to 0.24;
k = 1; N = 77; MADRS: mean 12.29, SD 7.52, n = 39 versus
mean 15.76, SD 8.14, n = 38; MD -3.47, 95% CI -6.97 to 0.03;
k = 1; N = 77).
The authors of this trial also analysed longitudinal changes in de-
pression scores, based on the assessments at baseline and at nine,
15, and 19weeks. They reported that whilst “[b]oth patient groups
displayed a significant reduction in self-reported symptoms of de-
pression...only the DBT-A group showed a significant reduction
in interviewer-rated depression...” (Mehlum 2014, p.7).
2.4 Hopelessness
There was no evidence of a treatment effect of DBT-A on hope-
lessness at the post-intervention assessment (Analysis 1.7; k = 2;
N = 101). There was, however, evidence of a significant difference
by comparator condition (i.e., TAU versus enhanced usual care;
Analysis 1.7; test for subgroup differences: Chi² = 5.13; df = 1; p =
0.02; I² = 80.5%). When compared to enhanced usual care, DBT-
A was associated with a significant improvement in hopelessness
scores at the post-intervention assessment (SMD -0.47, 95% CI
-0.93 to -0.02; k = 1; N = 77).
2.5 Suicidal ideation
There was evidence of an overall benefit of DBT-A on suicidal
ideation at the post-intervention assessment (Analysis 1.8; SMD
-0.62, 95% CI -1.07 to -0.16; k = 2; N = 100), but with no
evidence of a significant difference by comparator condition (i.e.,
TAU versus enhanced usual care; Analysis 1.8; test for subgroup
differences: Chi² = 1.15; df = 1; p = 0.28; I² = 13.3%).
2.6 Problem-solving
There were no data available for this outcome.
2.7 Suicide
Data obtained by correspondence with study authors indicated
that there were no suicides in either group during the treatment
period or over the 12 month follow-up period. Correspondence
with study authors for Mehlum 2014 further indicated that al-
though information on outcomes over a 24 month follow-up pe-
riod are still being collected, of those participants followed until
the date of correspondance, none had died by suicide.
Mentalisation
One study investigated the effectiveness of mentalisation-based
therapy in 12 to 17 year olds diagnosed with comorbid depression
presenting to emergency departments or community psychiatric
services following an episode of self-injury or self-poisoning, irre-
spective of whether suicidal intent was present (Rossouw 2012a;
N = 80).
Primary outcome
2.8 Repetition of SH
At the 12 month (post-intervention) assessment, significantly
fewer adolescents scored above the cut-point on the Risk-Taking
and Self-Harm Inventory (RTSHI), indicating that they had en-
gaged in fewer episodes of SH behaviour based on information
recorded over the preceding three months (Analysis 1.1; OR 0.26,
95% CI 0.09 to 0.78; k = 1; N = 71). The quality of evidence was
moderate (Summary of findings 2).
The study authors also measured longitudinal changes in scores
on the RTSHI and found that although “[b]oth groups showed
significant reductions in self-harm...following both a linear and
a quadratic pattern. The interaction term for group x time was
also significant...indicating that the linear decrease in RTSHI was
significantly greater for the [mentalisation-based therapy for ado-
lescents] group” (Rossouw 2012a, p.1308).
Secondary outcomes
2.9 Treatment adherence
There was no evidence of a significant treatment effect in terms
of the number of adolescents in each group who completed all 12
months of treatment (Analysis 1.5).
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2.10 Depression
Adolescents in the intervention group had significantly lower
scores on the depression sub-scale of the MFQ at the 12 month
(post-intervention) assessment (Analysis 1.6; MD -2.28, 95% CI
-2.81 to -1.75; k = 1; N = 80).
Depression was also measured dichotomously as the proportion
of participants scoring above the cut-point on the depression sub-
scale of the MFQ. Although fewer adolescents in the intervention
group scored above the cut-point for depression, there was no
evidence of a significant treatment effect at the 12 month (post-
intervention) assessment (19/39 versus 25/37; OR 0.46, 95% CI
0.18 to 1.16; k = 1; N = 76).
Changes in depression scores were also measured longitudinally
in the original report of this trial. The study authors found that
“[t]he level of self-rated depression decreased for participants in
both groups...The linear rate of decrease was somewhat greater for
the MBT-A group (P < 0.04) and the model yielded a significant
difference at 12 months” (Rossouw 2012a, p.1308).
2.11 Hopelessness
There were no data available for this outcome.
2.12 Suicidal ideation
There were no data available for this outcome.
2.13 Problem-solving
There were no data available for this outcome.
2.14 Suicide
Correspondence with study authors confirmed that no participant
died by suicide during the 12 month follow-up period.
Comparison 3: group-based psychotherapy versus
TAU
The effectiveness of group therapy was assessed in three studies
of 12 to 17 year olds referred to child and adolescent services
following an episode of intentional self-injury or self-poisoning,
irrespective of intent, over a follow-up period of seven months
(Wood 2001a; N = 63) or 12 months (Green 2011; N = 366;
Hazell 2009; N = 68).
Given that Hazell 2009 and Green 2011 were based in a large part
on Wood 2001a, employed the same treatment manual (Wood
2001b), and involved the authors of the earlier trial in the design
of the therapeutic intervention, we grouped these trials within
a single analysis. In all three trials, the content of group ther-
apy involved a variety of techniques, including CBT, PST, DBT,
and group psychodynamic psychotherapy. Therapy consisted of
six weekly acute group sessions, followed by weekly or bi-weekly
group therapy sessions continuing until the adolescent felt ready
to leave the service.
Primary outcome
3.1 Repetition of SH
There was no clear evidence of a difference in treatment effect of
group therapy on repetition of SH during either the six month
(Analysis 2.1; k = 2; N = 430) or 12 month (Analysis 2.2; k = 3; N
= 490) intervals after entry to treatment. A low quality of evidence
was found for both analyses (Summary of findings 3). Addition-
ally, both of these analyses were associated with considerable het-
erogeneity (I2 = 65% and 77%, respectively) with, at six months,
evidence of a significant adverse effect apparent in Hazell 2009.
While we were unable to undertake formal investigation into the
source of heterogeneity, it should be noted that in Wood 2001a,
the definition of repetition of SH was based on there being two
or more further episodes whilst in Hazell 2009 and Green 2011,
repetition was based on there being any further episodes of SH.
Also,Wood 2001a and Hazell 2009 were relatively small such that
chance findings may be more likely.
Secondary outcomes
3.2 Treatment adherence
There were no data available for this outcome.
3.3 Depression
There was no clear evidence of a difference in treatment effect for
depression at either the six month (Analysis 2.3; k = 2; N = 420)
or 12 month (Analysis 2.4; k = 3; N = 473) assessments.
3.4 Hopelessness
There were no data available for this outcome.
3.5 Suicidal ideation
There was also no clear evidence of a difference in treatment effect
for suicidal ideation at either the six month (Analysis 2.5; k = 2;
N = 421) or 12 month (Analysis 2.6; k = 3; N = 471) assessments.
3.6 Problem-solving
There were no data available for this outcome.
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3.7 Suicide
There were no suicides in either group in any of the three studies.
Comparison 4: therapeutic assessment versus TAU
(standard assessment)
One cluster randomised controlled trial examined the effective-
ness of therapeutic assessment for the treatment of SH in ado-
lescent patients in terms of repetition of SH in a sample of 12
to 18 year olds referred for a psychological assessment following
an episode of self-injury or self-poisoning irrespective of intent at
both 12 months (Ougrin 2011a, ISRCTN 81605131, N = 70)
and 24 months following entry to the study (Ougrin 2013, IS-
RCTN 81605131; N = 70).
As the study authors were unable to provide us with the values
of the either the inter-cluster correlation coefficient or the design
effect that would enable us to statistically account for the effects of
clustering (as per the guidance in Higgins 2011), results presented
in this section may overestimate the effectiveness of this interven-
tion.
Primary outcome
4.1 Repetition of SH
Therewas no evidence for a difference in treatment effect following
an episode of SH during either the 12 month (4/35 versus 5/34;
OR 0.75, 95% CI 0.18 to 3.06; k = 1; N = 69) or 24 month (7/
35 versus 9/34; OR 0.69, 95% CI 0.23 to 2.14; k = 1; N = 69)
follow-up periods. Quality of evidence was very low for both time
points (Summary of findings 4).
Secondary outcomes
4.2 Treatment adherence
Adolescents in the therapeutic assessment group were significantly
more likely to attend their first appointment (29/35 versus 17/35;
OR 5.12, 95% CI 1.70 to 15.39; k = 1; N = 70).
4.3 Depression
There were no data available for this outcome.
4.4 Hopelessness
There were no data available for this outcome.
4.5 Suicidal ideation
There were no data available for this outcome.
4.6 Problem-solving
There were no data available for this outcome.
4.7 Suicide
Correspondence with study authors confirmed that no partici-
pants died by suicide in either the intervention or control arms
during follow-up.
Comparison 5: compliance enhancement plus TAU
(standard disposition) versus TAU
One study investigated the effectiveness of standard disposition
(i.e., aftercare) planning with and without an added compliance
enhancement intervention over a three month follow-up period
in a sample of 12 to 19 year olds admitted to the emergency
department of a general hospital following an episode of self-injury
irrespective of intent (Spirito 2002; N = 76).
Primary outcome
5.1 Repetition of SH
There was no clear evidence of a difference in treatment effect
for repetition of SH by the six month follow-up assessment (3/29
versus 5/34;OR0.67, 95%CI0.15 to 3.08; k =1;N=63). Patients
in the compliance enhancement group did, however, “engage in
fewer repeat SH episodes” compared to participants in the control
group (mean 0.10 versus 0.15; Spirito 2002), although no more
details were available to allow formal testing of this. The quality
of evidence for this outcome was very low (Summary of findings
5).
Secondary outcomes
5.2 Treatment adherence
No clear evidence of a difference was found between the experi-
mental and control groups in relation to the number of partici-
pants attending at least one treatment session (27/29 versus 31/
34; OR 1.31, 95% CI 0.20 to 8.41; k = 1; N = 63), the average
number of sessions attended (mean 7.70, SD 5.80, n = 29 versus
mean 6.40, SD 4.40, n = 34; MD 1.30, 95% CI -1.28 to 3.88; k
= 1; N = 63), and completion of the full course of treatment (17/
29 versus 16/34; OR 1.59, 95% CI 0.59 to 4.33; k = 1; N = 63).
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5.3 Depression
There were no data available for this outcome.
5.4 Hopelessness
There were no data available for this outcome.
5.5 Suicidal ideation
There were no data available for this outcome.
5.6 Problem-solving
There were no data available for this outcome.
5.7 Suicide
No participants died by suicide in either arm.
Comparison 6: home-based family intervention
versus TAU
The effectiveness of a home-based family intervention was com-
pared with treatment as usual over a six month follow-up period in
one study in a sample of adolescents aged 16 years or younger re-
ferred to child and adolescent mental health services following an
episode of self-poisoning irrespective of intent (Harrington 1998;
N = 162).
Primary outcome
6.1 Repetition of SH
There was no evidence of a difference in treatment effect at the six
month assessment on the proportion of participants repeating SH
(11/74 versus 11/75; OR 1.02, 95% CI 0.41 to 2.51; k = 1; N =
149). The quality of evidence for this outcome was low (Summary
of findings 6).
Secondary outcomes
6.2 Treatment adherence
Although more participants in the home-based group completed
the full course of treatment, there was no clear evidence of a dif-
ference in treatment effect between the two groups (39/84 versus
28/77; OR 1.52, 95% CI 0.81 to 2.85; k = 1; N = 161).
6.3 Depression
There were no data available for this outcome.
6.4 Hopelessness
There was no evidence of a difference in treatment effect on hope-
lessness at the six month assessment (mean 4.40, SD 3.30, n = 74
versus mean 4.20, SD 3.60, n = 74; MD 0.20, 95% CI -0.91 to
1.31; k = 1; N = 148).
6.5 Suicidal ideation
There was also no evidence of a difference in treatment effect on
suicidal ideation at the six month assessment (mean 23.60, SD
40.00, n = 74 versus mean 28.70, SD 36.30, n = 75; MD -5.10,
95% CI -17.37 to 7.17; k = 1; N = 149).
6.6 Problem-solving
There was also no evidence of a difference in treatment effect on
problem-solving at the six month assessment (mean 17.60, SD
7.40, n = 73 versus mean 17.90, SD 7.30, n = 74; MD -0.30, 95%
CI -2.68 to 2.08; k = 1; N = 149).
6.7 Suicide
There was no evidence of a difference in treatment effect for sui-
cide. One patient in the experimental treatment group died by
suicide; none died by suicide in the control group. As the denom-
inator for intervention and control groups for this outcome are
not known, however, we could not calculate ORs.
Comparison 7: remote contact interventions versus
TAU
Emergency cards
One study investigated the effectiveness of an emergency card
enabling adolescents aged 16 years or younger who were admitted
to hospital following an episode of self-injury or self-poisoning
to re-admit themselves to a paediatric ward in the local hospital
on demand if they felt suicidal over a 12 month follow-up period
(Cotgrove 1995; N = 105). The control group participants in this
trial received treatment as usual, as did the experimental group (in
conjunction with the emergency card).
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Primary outcome
7.1 Repetition of SH
There was no clear evidence of a difference in treatment effect of
emergency cards on repetition of SH by the 12 month assessment
(3/47 versus 7/58; OR 0.50, 95%CI 0.12 to 2.04; k = 1; N = 105).
The quality of evidence for this outcome was very low (Summary
of findings 7).
Secondary outcomes
7.2 Treatment adherence
There were no data available for this outcome.
7.3 Depression
There were no data available for this outcome.
7.4 Hopelessness
There were no data available for this outcome.
7.5 Suicidal ideation
There were no data available for this outcome.
7.6 Problem-solving
There were no data available for this outcome.
7.7 Suicide
There were no data available for this outcome.
29Interventions for self-harm in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Dialectical behaviour therapy or mentalisation for adolescents compared to treatment as usual or other routine management
Patient or population: children and adolescents who engage in SH.
Settings: outpat ients.
Intervention: dialect ical behaviour therapy or mentalisat ion for adolescents.
Comparison: t reatment as usual or other rout ine management (i.e., enhanced usual care)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Treatment as usual Interventions for pa-
tients with multiple
episodes of SH or
emerging personality
problems
Dialectical behaviour therapy for adolescents (DBT-A)
Repetition of SH at
post- intervention
151 per 1000 113 per 1000
(21 per 439)
OR 0.72
(0.12 to 4.40)
105
(2 RCTs)
⊕⊕©©
LOW1,2
Quality was down-
graded as neither par-
t icipants nor clinical
personnel were blind
as to treatment alloca-
t ion. Quality was further
downgraded due to im-
precision in the ef fect
size est imate
Frequency of SH at
post- intervention
The mean f requency of SH episodes at post-
intervent ion in the intervent ion group was 0.79
lower (2.78 lower to 1.20 higher)
- 104
(2 RCTs)
⊕⊕©©
LOW1,2
Quality was down-
graded as neither par-
t icipants nor clinical
personnel were blind
as to treatment alloca-
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t ion. Quality was further
downgraded due to im-
precision in the ef fect
size est imate
M entalisation
Repetition of SH at
post- intervention
829 per 1000 557 per 1000
(303 to 790)
OR 0.26
(0.09 to 0.78)
71
(1 RCT)
⊕⊕⊕©
MODERATE1
Quality was down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SH: self -harm.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was rated as SERIOUS as the nature of the intervent ion means that clinical personnel could not have remained
blind to treatment allocat ion suggest ing that performance and detect ion bias may have been present.
2 Imprecision was rated as SERIOUS owing to the wide conf idence interval associated with the est imate of treatment ef fect.
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Group-based psychotherapy compared to treatment as usual
Patient or population: children and adolescents who engage in SH.
Settings: outpat ient.
Intervention: group-based psychotherapy.
Comparison: t reatment as usual
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Treatment as usual Group-based
psychotherapy
Repetition of SH at six
months
Study population OR 1.72
(0.56 to 5.24)
430
(2 RCTs)
⊕⊕©©
LOW1,2
Quality was down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion. Quality was fur-
ther downgraded due to
imprecision in the ef -
fect size est imate
726 per 1000 820 per 1000
(597 to 933)
Repetition of SH at 12
months
Study population OR 0.8
(0.22 to 2.97)
490
(3 RCTs)
⊕⊕©©
LOW1,2
Quality was down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion. Quality was fur-
ther downgraded due to
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imprecision in the ef -
fect size est imate
588 per 1000 533 per 1000
(239 to 809)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SH: self -harm.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was rated as SERIOUS as the nature of the intervent ion means that clinical personnel could not have remained
blind to treatment allocat ion suggest ing that performance and detect ion bias may have been present.
2 Imprecision was rated as SERIOUS owing to the wide conf idence interval associated with the est imate of treatment ef fect.
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Therapeutic assessment compared to treatment as usual (i.e. , standard psychosocial assessment) for self-harm in children and adolescents
Patient or population: children and adolescents who engage in SH.
Settings: outpat ients.
Intervention: therapeut ic assessment.
Comparison: t reatment as usual (i.e., standard psychosocial assessment)
Outcomes Illustrative comparative risks*
(95% CI)
Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Standard psychosocial
assessment
Therapeutic assess-
ment
Repetition of SH at 12
months
Study population OR 0.75
(0.18 to 3.06)
69
(1 RCT)
⊕⊕©©
LOW1,2
Quality was down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion. Quality was fur-
ther downgraded due to
imprecision in the ef -
fect size est imate
147 per 1000 115 per 1000
(30 to 345)
Repetition of SH at 24
months
Study population OR 0.69
(0.23 to 2.14)
69
(1 RCT)
⊕⊕©©
LOW1,2
Quality was down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion. Quality was fur-
ther downgraded due to
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imprecision in the ef -
fect size est imate
265 per 1000 199 per 1000
(76 to 435)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SH: self -harm.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was rated as SERIOUS as the nature of the intervent ion means that clinical personnel could not have remained
blind to treatment allocat ion suggest ing that performance and detect ion bias may have been present.
2 Imprecision was rated as SERIOUS owing to the wide conf idence interval associated with the est imate of treatment ef fect.
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Compliance enhancement plus treatment as usual (i.e. , standard disposition planning) compared to treatment as usual
Patient or population: children and adolescents who engage in SH.
Settings: outpat ient.
Intervention: compliance enhancement plus standard disposit ion planning.
Comparison: t reatment as usual (i.e., standard disposit ion planning).
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Treatment as usual Standard disposition
planning
Repetition of SH by six
months
Study population OR 0.67
(0.15 to 3.08)
63
(1 RCT)
⊕©©©
VERY LOW1,2
Quality was down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment al-
locat ion. Quality was
further downgraded as
details on blinding of
outcome assessors, in-
complete data and se-
lect ive report ing was
not adequately de-
scribed. Last ly, due to
imprecision in the ef -
fect size est imate, qual-
ity was further down-
graded
147 per 1000 104 per 1000
(25 to 347)
3
6
In
te
rv
e
n
tio
n
s
fo
r
se
lf-h
a
rm
in
c
h
ild
re
n
a
n
d
a
d
o
le
sc
e
n
ts
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
6
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SH: self -harm.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel
could not have remained blind to treatment allocat ion suggest ing that performance and detect ion bias may have been
present. Addit ionally, details on blinding of outcome assessors, incomplete data and select ive report ing was not adequately
described.
2 Imprecision was rated as SERIOUS owing to the wide conf idence interval associated with the est imate of treatment ef fect.
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Home-based family intervention compared to treatment as usual
Patient or population: children and adolescents who engage in SH.
Settings: outpat ients.
Intervention: home-based family intervent ion.
Comparison: t reatment as usual.
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding
risk
Treatment as usual Home-based family in-
tervention
Repetition of SH at six
months
Study population OR 1.02
(0.41 to 2.51)
149
(1 RCT)
⊕⊕©©
LOW 1
Quality was down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion
147 per 1000 149 per 1000
(66 to 301)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SH: self -harm.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was rated as SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel could not
have remained blind to treatment allocat ion suggest ing that performance and detect ion bias may have been present.
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Remote contact interventions compared to treatment as usual
Patient or population: children and adolescents who engage in SH.
Settings: outpat ients.
Intervention: remote contact intervent ions (emergency card).
Comparison: t reatment as usual.
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Treatment as usual Emergency card
Repetition of SH at 12
months
Study population OR 0.5
(0.12 to 2.04)
105
(1 RCT)
⊕©©©
VERY LOW 1,2
Quality was down-
graded as an open
random numbers table
was used to gener-
ate the allocat ion se-
quence and, as allo-
cat ion was not con-
cealed, there is possi-
ble select ion bias. Qual-
ity was further down-
graded as the nature of
this intervent ion means
it is unlikely part ici-
pants and clinical per-
sonnel would have been
blind to treatment allo-
cat ion and, as no de-
tails on outcome asses-
sor blinding were pro-
vided, performance and
detect ion bias cannot
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be ruled out. Last ly,
there was an error in
the randomisat ion se-
quence such that f ive
part icipants in the inter-
vent ion group either did
not receive emergency
cards, or alternat ively,
received them only af -
ter a delay thereby
invalidat ing follow-up
data for these f ive indi-
viduals
121 per 1000 64 per 1000
(16 to 219)
* The basis for the assumed risk (e.g., the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SH: self -harm.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Risk of bias was rated as VERY SERIOUS as the nature of the intervent ion means that part icipants and clinical personnel
could not have remained blind to treatment allocat ion suggest ing that performance and detect ion bias may have been
present. Addit ionally, as an open random numbers table was used to generate the allocat ion sequence and, as allocat ion
was not concealed, there is possible select ion bias. There was also an error in the randomisat ion sequence result ing in
f ive part icipants in the intervent ion group either not receiving the cards, or alternat ively, not receiving them until af ter a
substant ial delay thereby invalidat ing follow-up data for these individuals.
2 Imprecision was rated as SERIOUS owing to the wide conf idence interval associated with the est imate of treatment ef fect.
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D I S C U S S I O N
This systematic review is an update of previous versions of a
Cochrane review (Hawton 1998; Hawton 1999). It also adds to
raw data we provided to the UK’s National Institute for Clinical
Excellence in 2010 to contribute to its guidance on the longer-
term management of self-harm (NICE 2011). Whilst those ver-
sions included psychosocial and pharmacological interventions for
adults as well as children and adolescents who engage in SH, this
update is solely focused on interventions for children and adoles-
cents. Previously we commented on the small number of trials that
have focused on interventions for this population. Although for
this update we identified five additional trials, it is still surprising
that there have been so few trials in this population, especially
given the size of the problem of SH in young people in many
countries and the known association between SH and suicide.
In our previous reviewwe commented on the fact that themajority
of trials included either solely patients who had taken overdoses,
or samples in which the majority had. However, there are other
important patient subgroups, especially those who cut themselves.
None of the trials included in this review specifically focused on
these patients. However, such patients were included in many of
the trials, especially those where a large proportion (or all) of the
participants had a history of multiple episodes of SH at trial entry
(e.g., Green 2011; Hazell 2009; Mehlum 2014; Rossouw 2012a;
Wood 2001a). It should be noted that individuals who repeat
SH may change from one method of SH to another method in
subsequent episodes (Lilley 2008).
None of the included trials evaluated the effectiveness of phar-
macological agents in this patient group. Additionally, only one
included information on adverse effects of the intervention thera-
pies other than those relating to further suicidal behaviour (Hazell
2009).
We have used the intention-to-treat method where data allowed.
This was usually possible when examining the outcomes of repe-
tition of SH and suicide. Where outcomes relied on patient inter-
view, this was generally not possible and we have instead used all
available case data.
Summary of main results
Individual CBT-based psychotherapy
In a single trial of brief psychological therapy consisting of prob-
lem-solving and affect management training skills compared with
supportive relationship therapy (Donaldson 2005), no beneficial
effects of the psychological therapy were found in terms of repeti-
tion of SH, treatment adherence, depression, and suicidal ideation.
There was evidence of improved problem-solving on one measure
at 12 months but not on a second measure.
Interventions for patients with multiple episodes of SH or
emerging personality disorder
There was no apparent benefit for DBT-A, compared with either
TAU (Cooney 2010) or enhanced usual care (Mehlum 2014), us-
ing cross-sectional analyses of the proportion of participants re-
peating SH (Cooney 2010) or the numbers of SH episodes per
patient by the end of the therapy period (Cooney 2010; Mehlum
2014). However, in Mehlum 2014, the authors analysed the lon-
gitudinal slope of decline in mean number of SH episodes per
participant based on information reported at the baseline, nine
week, and 15 week assessments, and reported a significant benefit
for DBT-A. It is difficult to rationalise these two sets of results.
The results of our analyses suggest that any differences between
the groups following treatment were not marked.
There was no apparent treatment effect in the second trial on de-
pression using data from both the Self-report Mood and Feelings
Questionnaire (SMFQ) and the Montgomery-Åsberg Depression
Rating Scale (MADRS) based on analyses of the post-intervention
scores. However, again when the authors of the Mehlum 2014
trial used a longitudinal analysis based on scores from the SMFQ,
it suggested significant positive benefits of DBT-A on depression.
Again, the difference between the result of this analysis and ours
based on post-treatment results would suggest that any treatment
effect was not marked. Our analyses showed significant benefits of
DBT-A for both hopelessness and suicidal ideation at the 19 week
(post-intervention) assessment in Mehlum 2014 but not at the
post-intervention assessment in Cooney 2010. There is therefore
some evidence of beneficial effects for DBT-A, although the evi-
dence regarding repetition of SH and depression must currently
be regarded as equivocal.
In a single trial of mentalisation-based therapy, there was a sig-
nificant effect on repetition of SH in favour of mentalisation at
the post-intervention assessment (Rossouw 2012a). However, this
was based on fewer adolescents scoring above the cut-point on the
Risk Taking and Self-Harm Inventory (RTSHI) and it is unclear
how this scale may relate to actual SH behaviour.
There was no apparent beneficial effect of mentalisation on de-
pression as measured by the Mood and Feelings Questionnaire at
the post-intervention assessment. However, it is worth noting that
considerably fewer adolescents in the mentalisation group scored
above the cut-point for depression at the 12-month assessment,
although the study was relatively underpowered for this outcome
criterion (n = 40 per treatment arm). Changes in depression scores
were alsomeasured longitudinally in the original report of this trial.
The study authors found that “[t]he level of self-rated depression
decreased for participants in both groups...The linear rate of de-
crease was somewhat greater for the MBT-A group (P < 0.04) and
themodel yielded a significant difference at 12 months” (Rossouw
2012a, p.1308). These results suggest there might be benefits for
mentalisation over usual care, but this treatment approach requires
evaluation in further trials before a stronger conclusion can be
reached.
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Group-based therapy
Three trials investigated group-based therapy in adolescents with
a history of multiple SH episodes (Green 2011; Hazell 2009;
Wood 2001a). There was no overall evidence of apparent benefit of
group psychotherapy on repetition of SH. However, considerable
heterogeneity was associated with the results of the earlier two
studies (Hazell 2009; Wood 2001a), whilst the results of the third
much larger trial indicated no superiority of group-based therapy
compared with treatment as usual (Green 2011).
Therapeutic assessment
Given the known poor treatment adherence of adolescents who
engage in SH (Granboulan 2001; Taylor 1984), efforts have been
made to increase adherence through therapeutic assessment fol-
lowing SH. In a single trial a therapeutic assessment approach
appeared to considerably increase treatment adherence in terms
of the number of participants who attended the first treatment
session as compared to treatment as usual (Ougrin 2011a). There
were, however, no apparent beneficial effects in terms of repetition
of SH at 12 or 24 months. These results are based on a single
cluster randomised trial, which may overestimate the effectiveness
of this intervention.
Compliance enhancement
In a single small trial, compliance enhancement did not result in
improved outcomes comparedwith standard treatment in terms of
treatment adherence or repetition of SH (Spirito 2002). However,
the trial was probably underpowered to evaluate these outcomes.
The findings of this study are at odds with that of therapeutic as-
sessment (Ougrin 2011a), which also focused on enhancing treat-
ment adherence. However, the latter trial appeared to involve a
more intensive and pro-active therapeutic approach as part of the
assessment.
Home-based family intervention
A home-based family intervention did not appear to produce a
better outcome than standard treatment in terms of repetition of
SH, suicidal ideation, problem solving, and hopelessness. How-
ever, Harrington 1998 did report that parents were more satisfied
with the home-based family intervention at initial follow-up.
Remote contact interventions
In a single study to assess the effects of provision of an emergency
card allowingpatients to re-admit themselves to hospital (Cotgrove
1995), there was no difference in repetition of SH between the
intervention and control groups. However, the study appeared to
be underpowered to properly test this outcome. Few adolescents
made use of the emergency card, but none of those who did re-
peated SH.
Overall completeness and applicability of
evidence
Completeness of evidence
There have been relatively few trials of interventions for adolescent
SH patients (we identified just 11), especially compared with the
numbers of trials of psychosocial treatments for adults. Therefore
our conclusions are limited to a small range of interventions and
outcomes. Additionally, as there were no eligible trials of pharma-
cological interventions, perhaps due to concerns about safety in
this clinical population, our findings are limited to psychosocial
interventions.
A range of interventions have been investigated, including modifi-
cations of existing assessment procedures and attempts to increase
participant adherence, as well as specific aftercare interventions.
Mostly, however, these evaluations have been limited to single tri-
als. Three trials focused on group-based psychotherapy, which is
perhaps unsurprising given the initial optimism associated with
the publication of the first trial of group-based therapy in 2001
(Wood 2001a). There were two trials of DBT-A; all other inter-
ventions, including brief psychological therapy andmentalisation,
were evaluated only in single trials.
In the previous versions of this review we only focused on a sin-
gle clinical outcome, namely repetition of SH and suicide. In this
update we have considerably expanded the range of clinically rele-
vant outcomes that have been examined to include treatment ad-
herence, depression, hopelessness, suicidal ideation, and problem-
solving where available. We have also reported on the frequency
of SH where these data were available. However, limited data were
available on secondary outcomes. Only four trials included infor-
mation on depression, five on suicidal ideation, three on hopeless-
ness and two on problem-solving. Information on suicide had to
be requested from study authors for all 11 trials.
Applicability of evidence
The participants in the included trials appear to have been reason-
ably representative of adolescents who present to hospital follow-
ing SH, including a greater proportion of female participants in
all trials that recorded information on gender. Four trials focused
specifically on individuals with a history of multiple episodes of
SH, which is a particular concern in this clinical population given
its association with subsequent repetition (Hawton 2012c). In two
further trials around one-half of participants had a history of mul-
tiple episodes of SH.
It should be noted that this review is focused exclusively on chil-
dren and adolescents who have engaged in SH. As a result, we
have excluded patients with conditions such as emergent border-
line personality disorder who have not engaged in SH, and mixed
trials of patients with either SH or suicidal ideation in the absence
of suicidal behaviour.
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Quality of the evidence
The trials included in this review were, in general, relatively small
to detect significant differences in proportions of patients who en-
gaged in a repeat episode of SH. Additionally, quality of evidence,
as assessed using the GRADE approach, was, in general, low sug-
gesting that further research is likely to have an important im-
pact on our confidence in the estimate of treatment effectiveness,
and may, in fact, change the estimate. This is particularly likely
to affect results on those interventions that have so far only been
assessed in single trials. However, it should be noted that because
of the virtual impossibility of blinding participants and clinical
personnel to treatment condition in psychosocial intervention tri-
als such, studies are always likely to receive relatively low quality
ratings.
Limitations in design and implementation
All trials included in this review possessed high risk of bias in
relation to at least one aspect of trial design, with weaknesses most
commonly observed with respect to blinding of both participants
and clinical personnel. In part this may be due to the fact that
psychological interventions predominated in this review and we
believe it is generally not possible to blind participants or clinical
personnel to psychological therapy. Such trials are therefore always
likely to receive relatively low ratings. Nevertheless, performance
and detection bias cannot be ruled out.
Indirectness of evidence
Repetition of SH was measured using self-reported information,
medical records, or representation to hospital in all trials included
in this review. Secondary outcomes were assessed using widely
validated psychometric measures (such as MFQ, SIQ) that were
not subjected to modification in scoring.
Unexplained heterogeneity of inconsistency of results
Meta-analysis was only undertaken for two interventions: DBT-A
and group-based therapy. Considerable heterogeneity was, how-
ever, found for the three trials included in the latter analyses, par-
ticularly with respect to the primary outcome of repetition of SH
(I2= 65% for repetition at six months and I2= 77% for repetition
of SH at 12 months). I2 values for all other secondary outcome
measures equalled zero. It is possible that differences in available
services, and hence in treatment as usual more broadly, might be
one explanation for this heterogeneity. Another might be that a
different definition of repetition was used in the first trial (Wood
2001a), namely two or more further SH episodes. However, it
may also be that group-based therapy does not adequately address
the psychological needs of young people who have a history of
multiple SH episodes (Townsend 2014) or, possibly, treatment of
adolescent repeaters of SH in a group may carry risks of encour-
aging repetition through contagious influences (Hawton 2012a).
Imprecision of results
Results of the individual trials included in this review were asso-
ciated with a high level of imprecision as indicated by the wide
confidence intervals around the effect size estimates.
Probability of publication bias
Presence of publication bias could not be formally evaluated in this
review as no meta-analysis included ten or more trials. However,
it is notable that one trial was not published in full in a peer-
reviewed journal (Cooney 2010).
Potential biases in the review process
We have no reason to believe we have not identified all relevant
trials of interventions for SH in children and adolescents. By us-
ing the random-effects model in all analyses, our results possess
greater generalisability than if we had used the fixed-effect model
(Erez 1996). However, because our review criteria included only
studies of patients who had all engaged in SH and presented to
child and adolescent clinical services in the preceding six months,
we excluded trials where only some of the patients had engaged in
SH. Thus, for example, trials of adolescents with suicidal ideation
were excluded. Positive results of some trials which have included
such participants suggest a possible preventive role of more in-
tensive forms of psychotherapy, including, for example, multisys-
temic therapies in adolescents who SH (e.g., Huey 2004). How-
ever, such an assumption requires further evaluative research, es-
pecially given the recognised differences between adolescents who
have ideas of SH and those that actually engage in SH (O’Connor
2012). We also excluded studies where SH was an outcome in
studies of general interventions for patients with psychiatric disor-
ders. Data on repetition of SH were available for all the included
trials and information on suicides was available for all but one trial
(although there was only one such event recorded).
We only included trials in which adolescents engaged in SH and
presented to clinical services. For those who do not present to ser-
vices possible therapeutic approaches include online/bibliotherapy
interventions, or screening adolescents to identify those at risk.
We categorised the interventions in this review based on consen-
sus discussions among the review team who have considerable ex-
perience in both research and clinical practice related to SH. We
believe this approach is more informative and far less misleading
than where reviewers have combined disparate therapies in an at-
tempt to evaluate whether psychosocial therapy in general might
be effective, irrespective of the specific content of the interven-
tions, which provides little useful information for clinicians. Nev-
ertheless, we have combined interventions only where the thera-
peutic model is similar between trials. For this reason, meta-anal-
ysis was undertaken for only two interventions (i.e., DBT-A and
group-based psychotherapy). Both trials of DBT-A, Cooney 2010
and Mehlum 2014, refer to the original manualised adaption of
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DBT for adolescents (Miller 2007).We therefore believe that these
two trials are based on the same therapeutic model and are suf-
ficiently similar to justify pooling within meta-analysis. The lat-
ter two replications of group-based psychotherapy, Green 2011
and Hazell 2009, refer to the original trial of this therapy (Wood
2001a); all three trials were based on the same therapeutic model
and all recruited adolescents with a history of multiple episodes of
SH.We therefore believe that these three trials are also sufficiently
similar to justify pooling within a second meta-analysis.
Agreements and disagreements with other
studies or reviews
We identified 11 reviws of interventions for children and adoles-
cents following SH. Ten were systematic reviews (Brausch 2012;
Daniel 2009; Gonzales 2013; Gould 2003; Newton 2010; Nock
2007; Ougrin 2011b; Ougrin 2012; Ougrin 2015; Robinson
2011), and one was a narrative review (Brent 2013). All reviews in-
cluded both randomised and non-randomised trials and some also
included findings relating to adults who had self-harmed. Only
two included meta-analyses (Ougrin 2011b; Ougrin 2015). How-
ever, these pooled very disparate treatment approaches with likely
differing therapeutic mechanisms of action and patients with dif-
ferent characteristics (especially in terms of frequency of prior rep-
etition of SH).
A number of these reviews focused specifically on engagementwith
treatment, although no one intervention was found to be signifi-
cantly better than treatment as usual for engaging adolescents in
subsequent treatment (Ougrin 2011b; but seeOugrin 2011a in the
present review). With respect to repetition of SH, several reviews
suggest that DBT-A (Brausch 2012; Gonzales 2013; Gould 2003;
Nock 2007), hospital-based interventions (Brent 2013), transi-
tional interventions (Newton 2010), or those with a brief cog-
nitive behavioural or problem-solving orientation (Daniel 2009;
Robinson 2011), may show promise for the treatment of suicidal
behaviour in adolescents. However, these recommendations are
typically based on data from non-randomised trials, or from trials
in adults.
Group-based therapy was also identified as a potentially useful
treatment in one review (Gonzales 2013), on the basis of data from
one RCT in adolescents (Green 2011). However, we found no
evidence of a significant treatment effect for this trial, including
in terms of reduced repetition of SH, at either six or 12 months
follow-up (we also found no evidence of a significant treatment
effect for all other outcomes in this trial). Multisystemic therapy
was also found to be effective in one review for reducing suicide
attempts in adolescents experiencing a variety of psychiatric crises,
but not in those with a history of SH specifically (Ougrin 2012).
For the trial by Mehlum 2014, Ougrin 2015 reported data on
the proportions of participants who repeated SH, irrespective of
whether this resulted in hospital presentation (the only data avail-
able for the present review) or not. This apparently showed a sig-
nificant difference, with fewer participants in the DBT-A group
repeating SH than in the control group. However, correspondence
with the study author indicated that these data have not been re-
leased. The only relevant datawere presented in an interim analysis
on an initial sample of participants, not the full study population.
We were unable to obtain the final study data for this outcome.
The lack of evidence for the effectiveness of pharmacological inter-
ventions for SH in adolescents is also highlighted in several of these
reviews. However, as noted in the How the intervention might
work section, concerns about safety of drug therapy in young peo-
ple may partly explain this.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There have been relatively few investigations into interventions
for children and adolescents who engage in SH. Thus there is
not much evidence on which to draw conclusions on effects of
interventions for SH in this population. While there were some
very limited positive findings regarding DBT-A, mentalisation,
and therapeutic assessment, these approaches require further eval-
uation before any definitive conclusions about their use in clinical
practice can be made. Results of this review would suggest that a
comprehensive therapeutic assessment may increase engagement
with subsequent treatment. Although this finding is based on a
single cluster randomised trial which may overestimate the effec-
tiveness of the intervention, this result suggests that a compre-
hensive therapeutic assessment might be a useful part of a clinical
intervention.
However, on the strength of the evidence from three trials, includ-
ing one recent larger trial, there is little support for group-based
therapy for adolescents with a history of multiple episodes of SH.
Additionally, it is notable that the authors of one of these trials
reports an incident in which one participant posted confidential
information about another participant on an online blog (Hazell
2009), highlighting the potential risks associatedwith group-based
therapy in this clinical population.
Implications for research
While there were no very strong positive findings from the review,
some of the results regarding therapeutic assessment, mentalisa-
tion, and DBT-A suggests that these approaches warrant further
evaluation.
Given the evidence for its benefit in adults who engage in SH
(NICE 2011), individual CBT-based psychotherapy needs to be
further developed and evaluated in children and adolescents. The
development of this type of treatment could benefit from being
based on detailed investigation of the psychological factors con-
tributing to SH in children and adolescents, including factors that
44Interventions for self-harm in children and adolescents (Review)
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might enhance resilience and thereby reduce the risk of further
SH, as well as having benefits for other outcomes. Ideally, the de-
velopment of new treatments should ensure their feasibility and
suitability for the young people for whom they are designed (Craig
2008); children and adolescents with experience of SH and their
carers should be involved in this process. Heed should also be paid
to the principles of development and evaluation of treatments as
laid out in the UK Medical Research Council guidance regarding
complex interventions.
In trials of interventions for children and adolescents who engage
in SH, investigations of treatment could focus on subgroups of
adolescents, including those with a history of multiple episodes of
SH and those with a single or only few episodes, those with clearly
identified psychiatric disorders, especially depression, and those
with emergent borderline personality disorder. Specific treatments
for self-cutting and other forms of self-mutilation, which are com-
mon in adolescents, also merit development and evaluation.
In several trials in this review, especially the more recent trials,
a relatively broad range of outcome measures have been investi-
gated. This is to be encouraged in future trials. Any trial of an
intervention for SH in children and adolescents should include a
range of outcome measures; not just SH and suicide, but also ad-
herence, mood, and attitudes towards treatment, as this may help
to identify contributors to any apparent benefits or lack of impact.
Investigation of the mechanisms through which treatments might
work is also desirable to assist with the identification of clinically
relevant sub-groups of patients whomay benefit from certainmore
intensive forms of intervention. It is also important that any ad-
verse effects of treatment, such as the release of confidential infor-
mation described in the Hazell 2009 trial, are carefully evaluated.
It is essential that future trials in this patient population are ad-
equately powered to detect differences in key clinical outcomes,
especially repetition of SH.
The interventions we found to warrant further investigation given
some positive findings regarding frequency of repetition of SH -
mentalisation and DBT-A - both involve a core component of
intensive, relatively prolonged, one-on-one therapy suggesting that
where novel therapies for this population are considered, those
involving extended contact may be particularly valuable.
It is essential that future trials in this patient population are ad-
equately powered to detect differences in key clinical outcomes,
especially repetition of SH.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cooney 2010
Methods Allocation: random allocation using a computerised sequence.
Follow-up period: 6 months.
N lost to follow up: 0/29 (0%) for the primary outcome measure of repetition of SH
Participants Inclusion criteria: i) between 13 and 19 years of age; ii) at least one suicide attempt or
one episode of intentional self-injury within the 3 months preceding the pre-treatment
assessment; iii) in regular contact with at least one adult who was also willing and able
to attend treatment sessions as required; iv) proficient in English
Exclusion criteria: i) meets diagnostic criteria for an intellectual disability; ii) meets diag-
nostic criteria for a psychotic disorder
Numbers: Of the 29 participants, 14 were allocated to the experimental arm and 15 to
the control arm
Profile: 75.9% (n = 22) were female, 93.1% (n = 27) were diagnosed with comorbid
psychiatric disorders
Source of participants: patients referred to services following a suicide attempt or an
episode of intentional self-injury within the preceding 3 months
Location: Auckland, New Zealand.
Interventions Experimental: dialectical behaviour therapy specially adapted for adolescents composed
of weekly individual therapy sessions (50-60 minutes), weekly group skills training (110
minutes), and family therapy sessions and telephone counselling as required
Control: treatment as usual comprising individual and family sessions provided by a
multidisciplinary treatment team, medication management, and hospital or respite care
as required
Therapist: therapists with experience in delivering DBT.
Type of therapy offered: dialectical behaviour therapy for adolescents.
Length of treatment: 26 weeks.
Outcomes Included: i) repetition of SH according to self-report; ii) treatment adherence; iii) suicidal
ideation
Excluded: i) reasons for living; ii) emotion regulation; iii) treatment burden
Notes Source of funding: no details on funding were provided.
Declaration of author interests: “Dr. Emily Cooney and Dr. Kirsten Davis are both di-
rectors of a training company (DBTNZ) that is affiliated with Behavioral Tech LLC,
the training organisation mandated by the developer of dialectical behaviour therapy.
DBTNZ provides training in this therapy within New Zealand. Dr. Emily Cooney, Dr.
Kirsten Davis and Pania Thompson are all employed by the Kari Centre child and ado-
lescent mental health service within the Auckland District Health Board. This service
provides a DBT programme as a treatment for young people with emotion dysregulation
and repeated self-harm” (p.4)
Risk of bias
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Cooney 2010 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were randomly as-
signed…via a computerised randomisation
procedure…” (p.10)
Comment:Use of a computerised randomi-
sationprocedure is likely to haveminimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Low risk Quote: “Each treatment assignment was
placed in a sealed numbered envelope (32
envelopes in total) by the assistant…” (p.
10)
Comment: Use of opaque sealed envelopes
would ensure that allocation was ade-
quately concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: As this was a single, assessor-
blinded trial, we can assume that the par-
ticipants were not blinded as to treatment
allocation
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: As this was a single, assessor-
blinded trial, we can assume that clinical
personnel were not blinded as to treatment
allocation
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “All subsequent assessments were
administered by an assessor…who was also
blind to treatment condition” (p.10)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: Not stated. Although data for
all 29 participants randomised to the inter-
vention or control groups is reported at the
mid-treatment assessment, at longer fol-
low-up periods only data on those available
for assessment were presented
Selective reporting (reporting bias) Unclear risk Comment:No reason to suspect that all out-
comes were not measured, however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: No apparent other sources of
bias.
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Cotgrove 1995
Methods Allocation: random allocation using open number table.
Follow-up period: 12 months.
N lost to follow up: 0/105 (0%) for repetition of SH data.
Participants Inclusion criteria: i) aged 16 years or under.
Exclusion criteria: i) records of original suicide attemptmissing or those with “insufficient
follow-up data” (p.572)
Numbers:Of the 105 participants, 47 were allocated to the experimental arm and 58 to
the control arm
Profile: 85% (n = 89) were female, 6% (n = 6) were diagnosed with a major psychiatric
disturbance (not specified)
Source of participants: patients admitted to hospital following SH.
Location: North London, UK.
Interventions Experimental: emergency green card in addition to usual care. The green card acted as a
passport to re-admission into a paediatric ward at the local hospital
Control: standard follow-up including treatment from a clinic or child psychiatry de-
partment as required
Therapist: no details provided.
Type of therapy offered: emergency green card.
Length of treatment: 12 months.
Outcomes Included: i) repetition of SH according to clinical and hospital notes
Excluded: i) use of emergency card.
Notes Source of funding: no details on funding were provided.
Declaration of author interests: no details on author interests were provided.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “Adolescents were allocated ran-
domly” (p.570). Following correspondence
with the study authors, it became appar-
ent that a random open numbers table had
been used to generate the sequence
Comment: As the numbers table was open,
it is possible there may have been bias in
the generation of the random sequence
Allocation concealment (selection bias) High risk Comment: As the numbers table was open,
it is unlikely allocation could have been ad-
equately concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “Those in the treatment group re-
ceived a token, a green card, which acted as
a passport to re-admission into a paediatric
ward in their local hospital” (p.570)
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Cotgrove 1995 (Continued)
Comment: The nature of this study means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
Unclear risk Comment:Nodetails on blinding of clinical
personnel provided.
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: No details on blinding of out-
come assessors provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: Of the eligible 134 consecutive ad-
missions only “105 were included in the
follow-up study...”
Comment: Unclear as to why these partici-
pants were excluded.
Selective reporting (reporting bias) Unclear risk Comment:No reason to suspect that all out-
comes were not measured, however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias High risk Quote: “Forty seven adolescents (45%)
were randomly allocated to the treatment
group and 58 (55%) to the control.... The
reasons there were larger numbers in the
control group was partly due to chance,
and partly due to an error in one centre in
the way five of the green cards were issued;
either several weeks after discharge with-
out adequate explanation, or in a couple of
cases, not at all. This invalidated the follow-
up data from this centre for these five cases
in the treatment group, but not on those in
the control group.” (p. 572)
Comment: The inclusion of participants
who may have received the treatment in-
tervention within the control group may
lead to bias in the estimation of the treat-
ment effect, particularly as it is unclear how
these five cases were assessed. Additionally,
the authors claim the intervention was ef-
fective even though comparison of repeti-
tion rates was not significantly different be-
tween groups
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Donaldson 2005
Methods Allocation: Following correspondence with study authors, it became apparent that simple
randomisation using a random numbers table had been used to generate the allocation
sequence
Follow-up period: 3 and 6 months. Follow-up data on functioning for a sub-sample of
participants was available for 12 months
N lost to follow up: 8/39 (21%) for repetition data.
Participants Inclusion criteria: i) aged 12-17 years; ii) primary language was English; iii) outpatient
care indicated; iv) intent to die indicated
Exclusion criteria: i) psychosis indicated onmental status examination; ii) clinician judge-
ment that intellectual functioning precluded outpatient psychotherapy
Numbers: Of the 39 participants, 21 were allocated to the experimental arm and 18 to
the control arm
Profile: 48% (15/31) were repeaters, 29% (9/31) were diagnosed with major depression,
19% (6/31) were diagnosed with alcohol use disorder
Source of participants: patients presenting to a general paediatric emergency department
or inpatient unit of an affiliated child psychiatric hospital after a suicide attempt
Location: Northeast USA, possibly Providence, RI.
Interventions Experimental: Skills-based treatment focused on improving problem solving and affect
management skills. Additionally, participants were taught problem solving and cognitive
and behavioural strategies and given homework assignments to further improve their
skills. Treatment comprised two parts: i) active treatment for the first threemonths which
included six individual sessions and one adjunct family sessionwith two additional family
sessions and two crisis sessions available at the therapist’s discretion; ii) maintenance
treatment for the remaining three months which included three sessions
Control: Supportive relationship therapy focused on addressing the adolescent’s mood
and behaviour, including unstructured sessions which addressed reported symptoms and
problems, and fostered the development of specific skills not otherwise addressed during
treatment. This intervention was designed to resemble usual care for this population in
this community
Therapist: 5 clinicians and 2 individuals with master’s degrees provided treatment for
both study arms
Type of therapy offered: problem solving therapy.
Length of treatment: 6 months.
Outcomes Included: i) repetition of SH; ii) suicide; iii) suicidal ideation; iv) depression; v) problem
solving; vi) compliance
Excluded: i) anger.
Notes Source of funding: “This project was supported by NIMH (MH05749), the American
Foundation for Suicide Prevention, and the Harvard Pilgrim Research Foundation” (p.
113)
Declaration of author interests: No details on author interests were provided.
Other:Data on repetition of SHwere obtained from reports fromadolescents andparents.
Data on suicides were obtained following correspondence with study authors
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “[Participants were r]andomized to
one of two treatment conditions” (p.114)
Comment: Correspondence with study au-
thors confirmed that a randomnumbers ta-
ble was used to generate the allocation se-
quence. Use of a random numbers table is
likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Unclear risk Comment: No information on allocation
concealment was provided.
Blinding (performance bias and detection
bias)
Of participants
Unclear risk Comment: No information on participant
blinding was provided. However, both
treatments were so similar that it is possible
participants were unaware of which treat-
ment they were receiving
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “The same seven therapists provided
treatment in both...conditions” (p.114)
Comment: Therapists are likely to have
known which participant was receiving
which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Quote: “Outcome measures were adminis-
tered...by a trained bachelor’s degree level
research assistant” (p.115)
Comment:No information on outcome as-
sessor blinding was provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Follow-up data from all 31 fami-
lies who completed follow-ups (regardless
of number of treatment sessions attended)
were included in data analyses consistent
with an intent to-treat model” (p.115)
Comment: In addition to performing analy-
ses in line with the intention-to-treat prin-
ciple, the authors also compared study par-
ticipants at baseline to those who dropped
out of treatment and concluded there were
“no significant differences” in the results
obtained. Of the 39 randomised partici-
pants, 31 completed the 3 or 6 month eval-
uations
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Donaldson 2005 (Continued)
Selective reporting (reporting bias) Unclear risk Comment: Suicide data were obtained
through correspondence with the study au-
thors, suggesting that selective reporting
bias may have been present
Other bias High risk Comment:Contamination is possible given
that the same seven therapists delivered
both the experimental and control treat-
ments
Green 2011
Methods Allocation: randomised using a minimisation procedure controlling for: i) frequency of
SH; ii) diagnosis of conduct disorder; iii) diagnosis of major depression; iv) psychosocial
distress
Follow-up period: 6 and 12 months.
N lost to follow up: “Loss to follow-up was low (<4%)” (p.1).
Participants Inclusion criteria: i) aged 12 years to 16 years 11 months; ii) presenting to child and
adolescent services with a history of at least two episodes of SH in the previous 12months
Exclusion criteria: i) unable to communicate in English; ii) diagnosed with severe low
weight anorexia nervosa; iii) diagnosed with psychosis; iv) attends a special learning
disability school; v) currently in secure care
Numbers: of the 366 participants, 183 were allocated to the intervention arm and 183
to the control arm
Profile: 88.5% (n = 324) were female, 100% (n = 366) were multiple repeaters, 62.0%
(n = 227) were diagnosed with a depressive disorder; 33.3% (n = 122) were diagnosed
with a behavioural disorder
Source of participants: adolescents presenting to local child and adolescent services with
a history of at least two episodes of SH within the previous 12 months
Location: Manchester and Chester, UK.
Interventions Experimental: manualised developmental group psychotherapy involving elements of
cognitive behavioural therapy, dialectical behavioural therapy, and group psychotherapy
Control: treatment as usual according to the clinical judgement of the adolescents’ child
and adolescent mental health service team. Treatment as usual excluded any type of
group-based intervention
Therapists: clinicians with a minimum of thee years post-qualifying experience and who
also received training in delivering developmental group psychotherapy
Type of therapy offered: group psychotherapy
Length of treatment: Acute treatment phase: 6 weeks. Weekly booster sessions continued
for as long as required (maximum theoretical length of treatment unclear in trial report)
Outcomes Included: i) repetition of SH according to self- and/or collateral report; ii) suicide; iii)
suicidal ideation; iv) depression
Excluded: i) global functioning; ii) health economics information.
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Green 2011 (Continued)
Notes Source of funding: “This study was funded by the Health Foundation and sponsored by
the University of Manchester” (p.11)
Declaration of author interests: none stated.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Allocation was by minimisation
controlling for: high or low self harm...pres-
ence of behavioural disorder...or depressive
disorder...and presence or absence of high
psychosocial risk...” (p.4)
Comment: use of a minimisation algorithm
is likely to have minimised the role of bias
in the generatioU of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “Randomisationwas by remote tele-
phone...” (p.4).
Comment: Randomisation by remote tele-
phone would have enabled the allocation
sequence to have remained adequately con-
cealed
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “It was not possible to blind...the
participants themselves to treatment allo-
cation” (p.4)
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “It was not possible to blind clini-
cians...to treatment allocation” (p.4)
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The main outcomes were recorded
by outcome assessors blinded to treatment
allocation...Assessor guesses of allocation
following end point were no better than
chance” (p.4)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Analysis of primary and secondary
outcomes was by intention-to-treat subject
to availability of data” (p.4)
Comment: Although the authors describe
using an intention-to-treat approach to
analyses for both primary and secondary
outcomes, not all participants allocated to
the intervention and control groups are in-
cluded in subsequent analyses suggesting
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Green 2011 (Continued)
that outcome reporting may be incomplete
Selective reporting (reporting bias) Unclear risk Comment:No reason to suspect that all out-
comes were not measured, however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: No apparent other sources of
bias.
Harrington 1998
Methods Allocation: randomisation using a series of opaque sealed envelopes which contained
either a blank sheet or one bearing the letter F (for family therapy)
Follow-up period: 6 months.
N lost to follow up: 13/162 (8%) for repetition data.
Participants Inclusion criteria: i) 16 years of age or younger; ii) engaged in an episode of self-poisoning;
iii) living in a family
Exclusion criteria: i) engaged in self-cutting or hanging; ii) in social service care; iii)
current investigation of physical or sexual abuse; iv) diagnosed with a contraindicated
psychiatric condition (e.g., psychosis); v) currently in inpatient treatment; vi) parent or
child diagnosed with a learning disability; vii) parent or child seriously suicidal
Numbers:Of the 162 participants, 85 were allocated to the experimental arm and 77 to
the control arm
Profile: 89.5 % (n = 145) were female, 64.5% (n = 104) were diagnosed with major
depression, 10.5% (n = 17) were diagnosed with conduct disorder, 100% (n = 162) had
a history of self-poisoning
Source of participants: patients referred to mental health teams in one of four hospitals
Location: Manchester, UK.
Interventions Experimental:manualised home based family therapy intervention involving one assess-
ment session and 4 home visits in addition to treatment as usual
Control: treatment as usual.
Therapist: 2 psychiatric social workers with a master’s degree.
Type of therapy offered: family therapy.
Length of treatment: not stated.
Outcomes Included: i) repetition (data obtained from study authors); ii) suicide; iii) suicidal ideation;
iv) compliance; v) hopelessness; vi) problem solving; vii) depression
Excluded: i) family functioning; ii) satisfaction with treatment; iii) cost-effectiveness; iv)
parent General Health Questionnaire
Notes Source of funding: ”This research was supported by the Department of Health, London“
(p.517)
Declaration of author interests: no details on author interests were provided.
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: ”a series of opaque and sealed en-
velopes containing either a blank sheet or
the letter F were prepared and randomly
assorted by an assistant“ (p.2)
Comment: Although it is likely the random
sequence was adequately generated, with-
out further information on the method
used, this cannot be ascertained
Allocation concealment (selection bias) Low risk Quote: ”a series of opaque and sealed en-
velopes containing either a blank sheet or
the letter F were prepared and randomly
assorted by an assistant” (p.2)
Comment: Use of opaque sealed envelope
containing either a blank sheet or a sheet
with the letter F printed on it would ensure
that allocation was adequately concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this study means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “[The envelopes] were opened by
the social worker at the time of the as-
sessment, who then assigned the case to
the family intervention plus routine care or
routine care alone” (p.2)
Comment: Personnel were not blinded.
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Treatment assignment was entered
on a register and concealed from the out-
come assessors” (p.2)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Outcome assessments were con-
ducted with 154 (96%) of 162 cases at two
months and 149 (92%) of 162 cases at six
months” (p.3). “All the analyses were con-
ducted ‘intent to treat’” (p.3)
Selective reporting (reporting bias) Unclear risk Comment:No reason to suspect that all out-
comes were not measured, however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: No apparent other sources of
bias.
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Hazell 2009
Methods Allocation: random allocation conducted by a distant site coordinator.
Follow-up period: 12 months
N lost to follow up: 0/72 for repetition data.
Participants Inclusion criteria: i) aged between 12 and 16 years; ii) referred to a child and adolescent
mental health service in Newcastle, Brisbane North, or Logan; iii) reported at least two
episodes of self-harm in the past year, one of which occurred within the past 3 months
Exclusion criteria: i) required intensive treatment owing to an imminent risk of SH; ii)
diagnosed with acute psychosis; iii) diagnosed with an intellectual disability or other
disorder that would indicate the patient was unlikely to benefit from group therapy
sessions; iv) current level of SH risk precluded participation in group therapy sessions
Numbers: Of the 72 participants, 35 were allocated to the experimental arm and 37 to
the control arm
Profile: 90.3% (n = 65) were female, 100% (n = 72) were multiple repeaters, 4.1% (n =
3) had alcohol problems, 0% (n = 0) had substance misuse problems, 56.9% (n = 41)
were diagnosed with depression; 6.9% (n = 5) had a diagnosis of conduct/oppositional
defiant disorder
Source of participants: patients referred to a child and adolescent mental health service
who had reported at least two episodes of SH in the past year, one within the past 3
months
Setting: Newcastle, Brisbane North, and Logan, New South Wales and Queensland,
Australia
Interventions Experimental: group therapy involving CBT, social skills training, interpersonal psy-
chotherapy, group psychotherapy in addition to treatment as usual
Control: treatment as usual involving individual counselling, family sessions, medication
assessment and review, and other care co-ordination
Therapists: clinicians in community-based adolescent mental health services
Type of therapy offered: group psychotherapy.
Length of treatment: 12 months.
Outcomes Included: i) repetition of SH according to self-report; ii) suicide; iii) suicidal ideation; iv)
depression
Excluded: None
Notes Source of funding: no specific sources of funding were reported for this study
Declaration of author interests: “Prof. Hazell has received research funding from Celltach
and Eli Lilly; has served as a consultant to Eli Lilly, Janssen-Cilag, Novartis, and Shire;
and has participated in the speakers’ bureaus of Eli Lilly, Janssen-Cilag, and Pfizer. The
other authors report no conflicts of interest” (p.669)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: Correspondence with study au-
thors revealed that a computer generated
random number table was used to gener-
ate the random sequence. Randomisation
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by location and by blocks of four were also
used to ensure a similar number of adoles-
cents were recruited from each study loca-
tion
Allocation concealment (selection bias) Low risk Quote: “The local site co-ordinator emailed
the distant site co-ordinator, who assigned
a trial number and randomly allocated that
adolescent to group therapy or routine
care” (p.664)
Comment: Use of a remote site co-ordina-
tor is likely to have ensured allocation was
adequately concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Quote: “The adolescent was informed of his
or her allocation by a letter and by their
routine care therapist” (p.664)
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “The adolescent was informed of
his or her allocation by a letter and by their
routine care therapist” (p.664)
Comment: Given that the therapist is in-
forming participants as to their allocation,
this would suggest personnel were also not
blinded to allocation
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Treatment allocation was con-
cealed from the outcome assessors, who
were asked at the end of the study to nomi-
nate which treatment had been given to the
adolescents” (p.664)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Continuous outcomedatawere an-
alyzed on an intent-to-treat basis” (p.664)
Comment: Intention-to-treat analysesmade
using the last outcome carried forward
method
Selective reporting (reporting bias) Unclear risk Comment:No reason to suspect that all out-
comes were not measured, however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: No apparent other sources of
bias.
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Mehlum 2014
Methods Allocation: random allocation conducted by an external group using a permuted block
randomisation procedure
Follow-up period: 16 weeks (post-treatment).
N lost to follow up: 0/77 (0%).
Participants Inclusion criteria: i) history of at least two prior episodes of SH, one of which must have
occurred in the preceding 16 weeks; ii) meets at least two of the DSM-IV borderline
personality disorder criteria including the self-destructive criterion, or, at least one of
the DSM-IV borderline personality disorder criteria and at least two sub-threshold level
criteria; iii) fluent in Norwegian
Exclusion criteria: i) diagnosed with bipolar disorder (with the exception of bipolar II
disorder), schizophrenia, schizoaffective disorder, psychotic disorder not otherwise spec-
ified, intellectual disability, or Asperger’s syndrome
Numbers: Of the 77 participants, 39 were allocated to the experimental arm and 38 to
the control arm
Profile: 88.3% (n = 68) were female, 100% (n = 77) were multiple repeaters, 22.1% (n =
17) were diagnosed with major depression, 37.7% (n = 29) were diagnosed with another
depressive disorder, 26.0% (n = 20) were diagnosed with borderline personality disorder,
2.6% (n = 2) were diagnosed with substance use disorder
Source of participants: patients referred to a child and adolescent mental health service
who had reported at least two episodes of SH in the past year, one within the past 16
weeks
Setting: Oslo, Norway.
Interventions Experimental: dialectical behaviour therapy specially adapted for adolescents (DBT-A)
involving: weekly sessions of individual therapy, weekly sessions of multifamily skills
training, family therapy sessions, and telephone coaching as required
Control: enhanced usual care involving no less than one weekly individual therapy session
Therapists: psychologists and psychiatrists who received training in DBT-A specially for
this trial
Type of therapy offered: dialectical behaviour therapy.
Length of treatment: 19 weeks.
Outcomes Included: i) repetition of SH according to self-report and hospital records; ii) suicidal
ideation; iii) depression; iv) hopelessness
Excluded: i) borderline personality disorder symptom severity.
Notes Source of funding: “This study was funded by grants from the Norwegian Directorate of
Health, the South Eastern Regional Health Authority, the Extra-Foundation for Health
and Rehabilitation, and the University of Oslo” (p.9)
Declaration of author interests: no author reported any conflict of interest.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Treatment allocation of partici-
pants...was based on a permuted block ran-
domisation procedure with an undisclosed
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and variable blocking factor...” (p.2)
Comment: Use of a block randomisation
procedure is likely to have minimised the
role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Low risk Quote: “...management of the randomisa-
tion procedures was performed by an ex-
ternal group...” (p.2)
Comment: Use of remote site coordinators
is likely to have ensured allocation was ad-
equately concealed
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: This was a single, assessor-
blinded trial.
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: This was a single, assessor-
blinded trial.
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Ten independent assessors, blind
to treatment allocation and to results from
baseline interviews, conducted interviews
at trial completion...” (p.4)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Data analysis was by intention to
treat.” (p.5)
Selective reporting (reporting bias) Unclear risk Comment:No reason to suspect that all out-
comes were not measured, however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: No apparent other sources of
bias.
Ougrin 2011a
Methods Allocation: randomisation at the clinician level using permuted blocks (block lengths 22
and 4) using web-based randomisation software
Follow-up period: 12 and 24 months. Data for the 24 month follow-up period were
extracted from Ougrin 2013.
N lost to follow up: 0/70 (0%) for the primary outcome (i.e., attendance at scheduled
individual outpatient therapy sessions); 5/70 (7.1%) for secondary outcomes
Participants Inclusion criteria: i) aged 12-18 years; ii) presenting to emergency departments following
an episode of SH; iii) referred for psychological assessment at one of two Child and
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Ougrin 2011a (Continued)
Adolescent Mental Health Services
Exclusion criteria: i) currently receiving psychiatric treatment; ii) diagnosed with a dis-
order causing gross reality distortion (e.g., psychosis, acute intoxication); iii) history of
diagnosis for a moderate to severe learning disability; iv) unable to communicate fluently
in English; v) at immediate risk of violence or suicide; vi) requiring inpatient psychiatric
treatment
Numbers: Of the 26 clinicians, 13 were allocated to the experimental arm and 13 to the
control arm. Of the 70 participants, 35 received treatment from clinicians allocated to
the experimental arm and 35 received treatment from clinicians allocated to the control
arm
Profile: 80.0% (n = 56) were female; 58.6% (n = 41) were multiple repeaters
Source of participants: patients admitted to emergency departments following an episode
of SH
Location: London, UK.
Interventions Experimental: manualised therapeutic assessment involving standard psychosocial his-
tory and suicide risk assessment conducted according to NICE guidelines (NICE 2004)
, a review of this information, the identification of reciprocal roles, core pain, and mal-
adaptive procedures based on a cognitive analytic therapy paradigm, the identification
of target problems, consideration of the ways to change these problems, providing mo-
tivation to change these problems, exploring alternatives to solve these problems, and
the construction of an “understanding letter” summarising these steps to be sent to the
family
Control: standard psychosocial history and suicide risk assessment conducted according
to NICE guidelines (NICE 2004).
Therapist: clinicians who received a minimum of 5 weeks training in therapeutic assess-
ment
Type of therapy offered: therapeutic assessment.
Length of treatment: approximately 1 hour and 40 minutes.
Outcomes Included: i) repetition of SH; ii) suicide; iii) compliance.
Excluded: i) functioning; ii) strengths and difficulties.
Notes Funding source: “The study was funded from the following three sources: Psychiatry
Research Fund...Maudsley Charitable Fund...and West London Research Consortium”
(p.153)
Declaration of author interests: “...DOhas support fromPsychiatry ResearchTrust,Maud-
sley Charitable Funds and West London Research Consortium for the submitted work..
.AN, DO and TZ have royalties paid to them by Hodder Arnold Publishing that might
have an interest in the submitted work...DO, TZ, AN, RB, AB and ET have no non-
financial interests that may be relevant to the submitted work” (p.153)
Other: Adjustment was made for the effects of clustering within clinicians enabling the
inclusion of this study. Data on repetition of SH and suicide were obtained following
correspondence with study authors
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Quote: “Randomisation occurred at the as-
sessor level...The randomisation was strat-
ified by centre, and two blocks (block
lengths 22 and 4) were created using a per-
muted block design to ensure equal num-
bers from each centre being allocated to ei-
ther intervention or control groups. The
randomisation scheme was generated using
web-based randomisation software (http://
www.randomization.com)” (pp. 149-150)
Comment: Use of computer-based ran-
domisation software is likely to have min-
imised the role of bias in the generation of
the randomisation sequence
Allocation concealment (selection bias) Low risk Quote: “Randomisation was conducted by
a senior psychiatrist independent of the
study clinicians” (pp.149-150)
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: Correspondence with study au-
thors revealed that participants were not
blinded
Blinding (performance bias and detection
bias)
Of personnel
High risk Quote: “Itwas not possible to blind the clin-
icians to the intervention they were deliv-
ering” (p.150)
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “The study statistician and the
researchers conducting follow-up assess-
ments were unaware of the participants’ al-
location” (p.150)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “All 70 recruited participants were
analysed on the primary and secondary out-
come measures. Whenever the data were
missing we used the last observation avail-
able” (p.150)
Selective reporting (reporting bias) Unclear risk Comment:Data on repetition of SH had to
be requested from study authors, suggest-
ing that selective reporting bias may have
been present
Other bias Low risk Comment: No apparent other sources of
bias.
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Methods Allocation: randomisation using a minimisation procedure controlling for: i) age; ii)
gender; iii) number of prior hospital admissions for SH
Follow-up period: 3, 6, 9, and 12 months.
N lost to follow up: 9/80 (11.2%) for SH at the 12 month follow-up.
Participants Inclusion criteria: i) 12-17 years; ii) presented with at least one episode of SH within the
past month; iii) episode of SH was primary reason for referral to psychiatric services
Exclusion criteria: i) required inpatient psychiatric treatment; ii) diagnosedwith comorbid
psychosis, a severe learning disability, a pervasive developmental disorder, or an eating
disorder in the absence of SH; iii) diagnosed with any chemical dependence
Numbers: Of the 80 participants, 40 were allocated to the intervention arm and 40 to
the control arm
Profile: 85.0% (n = 68) were female; 96.2% (n = 77) were diagnosed with depression;
72.5% (n = 58) were diagnosed with borderline personality disorder
Source of participants: patients presenting to community health services or acute hospital
emergency rooms following an episode of SH
Location: London, UK.
Interventions Experimental: mentalisation-based treatment adapted for adolescents involving manu-
alised psychodynamic psychotherapy sessions for both the adolescent and his/her family
Control: treatment as usual according to current NICE guidelines (NICE 2004). “The
majority of...participants in the TAU group received the following: an individual ther-
apeutic session alone (28%), consisting of counselling (in 38% of cases receiving an
individual intervention), generic supportive interventions (24%), cognitive behavioral
therapy (19%), or psychodynamic psychotherapy (19%); a combination of individual
therapy and family work (25%); or psychiatric review alone (27.5%)” (p.1306)
Therapist: 22 therapists from a variety of different professional backgrounds who received
6 days training in delivering mentalisation-based treatment
Type of therapy offered: mentalisation.
Length of treatment: 12 months.
Outcomes Included: i) repetition of SH according to scores on SH scale of the Risk-Taking and Self-
Harm Inventory; ii) depression; iii) hopelessness; iv) compliance
Excluded: i) borderline personality disorder symptom severity; ii) feelings
Notes Source of funding: no details on funding are provided.
Declaration of author interests: “Dr. Fonagy is the Chief Executive of the Anna Freud
Centre, London, which regularly offers training courses in mentalization based treat-
ment...and National Clinical Lead for the Department of Health’s Improved Access to
Psychological Therapies (IAPT) for Children and Young People Programme. He has
received grant income from the National Institute of Clinical Excellence, the UKMental
Health Research Network, the British Academy, theWellcome Trust, the National Insti-
tute of Health Research (Senior Investigator Award and Research for Patient Benefit Pro-
gramme), the Pulitzer Foundation, the Department for Children, Schools, and Families,
the Central and East London Comprehensive Local Research Network (CLRN) Pro-
gramme, the NHS Health Technology Assessment (HTA) programme, the Department
of Health’s IAPT Programme, and the Hope for Depression Foundation. Dr. Rossouw
reports no biomedical, financial interests, or potential conflicts of interest” (p.1312)
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Rossouw 2012a (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Allocation was by minimization,
controlling for past hospital admissions,
gender, and age.” (p.1305)
Comment:Use of aminimisationprocedure
is likely to have minimised the role of bias
in the generation of the randomisation se-
quence
Allocation concealment (selection bias) Low risk Quote: “...participants were randomized by
an independent statistician working off-
site...” (p.1306)
Blinding (performance bias and detection
bias)
Of participants
Low risk Quote: “...participants were...blinded to as-
signment” (p.1305).
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the study means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “assessors...were...blinded to assign-
ment” (p.1305).
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Data analysis was by intention to
treat” (p.1306).
Selective reporting (reporting bias) Unclear risk Comment:No reason to suspect that all out-
comes were not measured, however, in the
absence of the trial protocol, this cannot be
ascertained
Other bias Low risk Comment: No apparent other sources of
bias.
Spirito 2002
Methods Allocation: randomisation using a random numbers table.
Follow-up period: 3 months.
N lost to follow up: 13/76 (17%) for repetition of SH data.
Participants Inclusion criteria: i) aged 12-18 years; ii) receiving medical care in either the emergency
department or paediatric ward of a children’s hospital following a suicide attempt
Exclusion criteria: none stated.
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Numbers: Of the 76 participants, 36 were allocated to the experimental arm and 40 to
the control arm
Profile: 63 (90%) were female.
Source of participants: patients presenting to hospital following a suicide attempt
Location: Northeast USA, possibly Providence, RI.
Interventions Experimental: compliance enhancement intervention plus standard disposition planning
involving a single, one-hour session that reviewed expectations for outpatient treatment as
well as addressing the factors likely to impede attendance and treatment misconceptions,
and encouraged both the adolescent and parent to make a verbal contract to attend all
treatment sessions. Participants were also contacted by telephone at 1, 2, 4, and 8 weeks
post-discharge to review their compliance with treatment
Control: standard disposition planning involving treatment based on judgment of psychi-
atric clinician who conducted the evaluation. Some participants in both the experimental
and control arms had a brief inpatient psychiatric stay prior to receiving outpatient care.
The remainder received outpatient care at local mental health centre
Therapist: 3 post-doctoral fellows in psychology.
Type of therapy offered: compliance enhancement.
Length of treatment: 8 weeks.
Outcomes Included: i) repetition of SH according to self- and parent-report, however, only data
from self-report was used; ii) suicide; iii) compliance
Excluded: i) problems concerning therapy sessions.
Notes Source of funding: “This investigation was supported by NIMH grant MH52411 and by
a grant from the van Amerigen Foundation” (p.435)
Declaration of author interests: not stated.
Other: In two cases a parent reported repetition of SH but the adolescent denied this
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomly assigned” (p.436)
Comment: Correspondence with study au-
thors clarified that the method used was a
“random numbers table.” Use of a random
numbers table is likely to have minimised
the role of bias in the generation of the ran-
domisation sequence
Allocation concealment (selection bias) Unclear risk Comment: no details on allocation conceal-
ment were provided.
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this study means
that participants could have known to
which group they had been allocated
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Spirito 2002 (Continued)
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the study means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Unclear risk Comment: No details on outcome assessor
blinding were provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Quote: “Adolescents who refused to par-
ticipate in the project (n = 6) were com-
pared on age and gender to those who were
enrolled. No significant differences were
found. In addition, adolescents who were
lost to follow-up (n = 13) were compared to
those who remained in the project. There
were no significant differences noted on
age, gender, race, [socioeconomic status],
or any of the baseline psychological mea-
sures” (p.437)
Comment: Although there was no indica-
tion that intention-to-treat analyses had
been conducted, efforts were clearly made
to establish whether results could be af-
fected by attrition bias
Selective reporting (reporting bias) Unclear risk Comment: Data on suicides had to be re-
quested from study authors, suggesting
that selective reporting bias may have been
present
Other bias Low risk Comment: No apparent other sources of
bias.
Wood 2001a
Methods Allocation: randomised allocation using trial numbers.
Follow-up period: 7 months
N lost to follow up: for repetition of SH, 1/32 (3.1%) in the experimental arm and 0/31
(0%) in the control arm
Participants Inclusion criteria: i) 12-16 years; ii) referred to child and adolescent mental health service
following an episode of SH; iii) a history of SH on at least one other occasion during
the preceding year
Exclusion criteria: i) diagnosed as too suicidal for ambulatory care by a senior child and
adolescent psychiatrist; ii) current situation precludes attendance at group sessions (e.g.
, incarcerated); iii) diagnosed with any psychosis; iv) diagnosed with learning problems
or any other disorder that made it unlikely they would benefit from group-based inter-
ventions
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Wood 2001a (Continued)
Numbers: of the 63 participants, 32 were allocated to the experimental arm and 31 to
the control arm
Profile: 100% (n = 63) were multiple repeaters who had engaged in SH an average of
4 times prior to study entry, most commonly by overdose and cutting, 83.9% (n = 52)
were diagnosed with major depression, 38.7% (n = 24) of the experimental group and
30.6% (n = 19) of the control group were diagnosed with conduct and/or oppositional
defiance disorder
Source of participants: patients referred to child and adolescent mental health service
following an episode of SH
Location: Manchester, UK
Interventions Experimental: developmental group psychotherapy involving a variety of techniques, in-
cluding: problem solving, CBT, DBT, and group psychodynamic psychotherapy inter-
ventions. Treatment comprised a one-off initial assessment phase, followed by 6 acute
group sessions, and weekly group therapy sessions continuing until the young person
felt ready to leave the intervention. Treatment as usual was also available as required
Control: treatment as usual delivered by community psychiatric nurses and psychologists
involving family sessions, non-specific counselling, and psychotropic medication where
indicated
Therapist: 2 therapists, a senior nurse, and a psychiatrist
Type of therapy offered: group psychotherapy.
Length of treatment: 6 months.
Outcomes Included: i) repetition of SH; ii) suicide; iii) suicidal ideation; iv) depression; v) compli-
ance
Excluded: i) admissions to hospital; ii) behavioural problems; iii) global outcomes
Notes Source of funding: “This research was supported by a project grant from the Mental
Health Foundation and by a Training Fellowship to Miss Trainor from the National
Health Service Executive North West” (p.1246)
Declaration of author interests: no details on author interests are provided.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “An independent statistician at a dis-
tant site...assigned a trial number and then
randomly allocated participants” (p.1247)
Comment: Use of assignment by a random
numbers technique is likely to have min-
imised the role of bias in the generation of
the randomisation sequence
Allocation concealment (selection bias) Low risk Quote: “Treatment allocation was con-
cealed from the outcome assessors” (p.
1247)
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Wood 2001a (Continued)
Blinding (performance bias and detection
bias)
Of participants
High risk Comment: The nature of this study means
that participants could have known to
which group they had been allocated
Blinding (performance bias and detection
bias)
Of personnel
High risk Comment: The nature of the study means
personnel are likely to have known which
participant was receiving which treatment
Blinding (performance bias and detection
bias)
Of outcome assessors
Low risk Quote: “Treatment allocation was con-
cealed from the outcome assessors” (p.
1247)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “We used the most stringent
[method of intention-to-treat analyses] in
which all randomized cases were included,
regardless of whether they started or com-
pleted treatment. The analysis was con-
ducted just once, all cases were analyzed as
allocated, and no interim or subgroup anal-
yses were permitted” (p.1248)
Selective reporting (reporting bias) Unclear risk Comment: Data on suicides had to be re-
quested from study authors, suggesting
that selective reporting bias may have been
present
Other bias Low risk Comment: No apparent other sources of
bias.
CBT: cognitive behavioural therapy
DBT: dialectical behavior therapy
DBT-A: dialectical behavior therapy for adolescents
SH: self-harm
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Asarnow 2011 Participants were not required to have engaged in SH prior to study entry
Bjärehed 2013 Participants were not required to have engaged in SH prior to study entry
Brent 2009 Not all participants were randomised to the intervention or control groups; some chose to receive the
intervention treatment
77Interventions for self-harm in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Carli 2011 Participants were not required to have engaged in SH prior to study entry
Deykin 1986 Non-randomised clinical trial.
Diamond 2010 Participants were not required to have engaged in SH prior to study entry
Donaldson 1997 Non-randomised clinical trial.
Dubois 1999 Greater than 10-15% of the sample were older than 18 years of age at study entry
Emslie 2006a Participants were not required to have engaged in SH prior to study entry
Emslie 2006b Participants were not required to have engaged in SH prior to study entry
Emslie 2007 Participants were not required to have engaged in SH prior to study entry
Emslie 2009 Participants were not required to have engaged in SH prior to study entry
Esposito-Smythers 2006 Participants were not required to have engaged in SH prior to study entry
Esposito-Smythers 2011 Participants were not required to have engaged in SH prior to study entry
Findling 2009 Participants were not required to have engaged in SH prior to study entry
Fleischhaker 2005 Non-randomised clinical trial in which data from only the intervention arm are presented
Huey 2004 Participants were not required to have engaged in SH prior to study entry
King 2006 Participants were not required to have engaged in SH prior to study entry
King 2009
Miller 2000 Non-randomised clinical trial.
Nixon 2003 Non-randomised clinical trial.
Oldershaw 2012 Participants were not required to have engaged in SH prior to study entry
Pineda 2013 Participants were not required to have engaged in SH prior to study entry
Podobnik 2012 Participants were not required to have engaged in SH prior to study entry
Ramani Perera 2011 Correspondence with study authors suggested alternate allocation to intervention and control groups,
rather than true randomisation
Robinson 2012 Participants were not required to have engaged in SH prior to study entry
78Interventions for self-harm in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Robinson 2014 Participants were not required to have engaged in SH prior to study entry
Rotheram-Borus 1996 Non-randomised clinical trial.
Sarchiapone 2013 Participants were not required to have engaged in SH prior to study entry
Vitiello 2009 Not all participants were randomised to the intervention or control groups; some chose to receive the
intervention treatment
Wilkinson 2011 Participants were not required to have engaged in SH prior to study entry
Xu 2006 Method of allocation to intervention and control groups unclear
SH: self-harm
Characteristics of ongoing studies [ordered by study ID]
Asarnow 2014
Trial name or title Family-based intervention for adolescent suicide attempters. Extension: Self-Harm and Suicide Attempt Risk:
Evaluation of an Intervention for Youths with Self-Harm Behaviour. The SAFETY Study
Trial Registration Number: NCT00692302.
Methods Allocation: single-blind randomisation.
Design: single-centre (hospital-affiliated outpatient psychiatric clinic)
Setting: hospital-affiliated outpatient psychiatric clinic in an academic medical centre
Follow-up period: 3 months.
Location: Los Angeles, USA.
Participants Males and females, between 11 and 18 years of age inclusive, selected for presence of suicide attempt within
the previous 3 months, were eligible for participation in this trial. An extension of this protocol also enables
those with a history of clinically significant self-harming behaviour to be included. Clinically significant self-
harming behaviour is defined as: 1) an episode of NSSI in the past 3 months; 2) this episode of NSSI is viewed
as indicating the presenting problem or a major part of the presenting problem (e.g., the youth presents with
NSSI plus suicidal ideation, or with NSSI plus depression), and 3) a pattern of repeated self-harm behaviour
is present as evident by a total or 2 or more lifetime episodes of NSSI and/or suicidal attempts
Interventions Those randomised to the intervention group received SAFETY, a cognitive-behavioural oriented family treat-
ment rooted in socio-ecological theory. Those randomised to the control group received enhanced treatment
as usual. In this study, enhancements included 2 additional elements: 1) parents and the youth attended
one session with a study clinician to discuss safety, self-harm, and suicide risk as well as the importance of
outpatient treatment to address these issues; and 2) care linkage support was also offered for a period of 12
weeks with monthly check-in sessions to support patients in linking up with community treatment through
the provision of motivational enhancement and problem-solving therapy
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Asarnow 2014 (Continued)
Outcomes Primary outcome: repeat episodes of self-harming behaviour at 3 months follow-up
Secondary outcomes: repeat episodes of NSSI and/or attempted suicide as separate outcomes at 3 months
follow-up, scores on a measure of depression for both the youth and his/her parents at 3 months follow-up,
scores on a measure of hopelessness at 3 months follow-up, scores on a measure of social adjustment at 3
months follow-up, and patient satisfaction at 3 months follow-up
Starting date December 2010.
Recruitment period closed: between December 2011 and July 2012.
Proposed end date: December 2014.
Contact information Name: Prof. Joan Asarnow (PI).
Affiliation: Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles
email: jasarnow@mednet.ucla.edu
Notes Prof. Joan Asarnow very kindly provided unpublished information relating to this trial. Please note that Dr.
Jennifer Hughes is the PI for the extension component of this trial focusing on youths presenting with NSSI
Cottrell 2014
Trial name or title Self-harm intervention, family therapy (SHIFT): A randomised controlled trial of family therapy versus
treatment as usual for young people seen after second or subsequent episodes of self-harm
Trial Registration Number: ISRCTN 59793150.
Methods Allocation: randomised.
Design: multi-centre (hospital and community).
Setting: community.
Follow-up period: 18 months.
Location: multiple locations around the north of England and London.
Participants Males and females, between 11 and 17 years of age, who have engaged in at least one episode of self-harm
as assessed by the local Child and Adolescent Mental Health team as well as at least one additional episode
of self-harm prior to the index presentation, will be included in this trial. Those diagnosed with severe
major depression necessitating psychiatric inpatient care will be excluded from participation. Self-harming
behavior includes any form of non-fatal self-poisoning or self-injury such as cutting, overdose, hanging, self-
strangulation, jumping from a height, and deliberately running in front of traffic regardless of the motive
and/or intent to die
N: 832.
Interventions Participants (and their families) randomised to the experimental group will receive up to 8 sessions over a 6
month period of family therapy delivered by qualified family therapists using a modified version of the Leeds
Family Therapy and Research Centre Systemic Family Therapy Manual
Outcomes Primary outcome: rates of repetition of self-harm leading to hospital admission within the 18 month follow-
up period
Secondary outcomes: number of participants engaging in self-harmwithin 12 months post-randomisation, cost
effectiveness of family therapy as measured by the cost of each self-harm event avoided due to family therapy,
number of subsequent self-harm episodes, time to subsequent self-harm episodes, severity of subsequent
episodes, dangerousness of the method/s used in any subsequent episode as measured by the Suicide Attempt
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Cottrell 2014 (Continued)
Self-Injury Interview, scores on the Beck Scale for Suicide Ideation, and scores on the Paediatric Quality of
Life Enjoyment and Satisfaction questionnaire
Starting date September 2009. First participant recruited April 2010.
Recruitment period closed: December 2013.
Follow-up period concludes: June 2015.
Contact information Name: Prof. David Cottrell (chief investigator).
Affiliation: Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds
email: d.j.cottrell@leeds.ac.uk
Notes Prof. David Cottrell very kindly provided unpublished information relating to this trial
Diamond 2014
Trial name or title Family Therapy as Hospital Aftercare for Adolescent Suicide Attempters
Trial Registration Number: NCT01195740.
Methods Allocation: randomised.
Design: single-centre (mental health inpatient unit).
Setting: community.
Follow-up period: 16 weeks.
Location: Philadelphia, USA.
Participants Male and female adolescents between 12 and 17 years of age, who made at least one suicide attempt in the
previous month were included in this trial. Preliminary results suggest 80% of participants were female, 65%
were of African-American ethnicity
Interventions Participants randomised to the experimental group received attachment based family therapy alongside en-
hanced usual care. Enhanced usual care is a facilitated referral process with ongoing clinical monitoring. Each
adolescent’s treating therapist was ultimately responsible for engaging and retaining the adolescent and their
family with treatment
Outcomes Primary outcome: scores on the Client Satisfaction Questionnaire and the Cornell Services Index measured at
16 weeks post-treatment
Secondary Outcomes: scores on various measures of attachment with parents (e.g., the Relatedness Scale and
the Relationship Structures Questionnaire), and scores on the Lethality of Suicide Attempt Rating Scale at 16
weeks post-treatment. Information on future suicide attempts and scores on the Beck Depression Inventory,
the Suicide Ideation Questionnaire, the Columbia Suicide-Severity Scale, and the Suicide Intent Scale were
also collected
Starting date April, 2009.
End date: May, 2011.
Contact information Name: Dr. Guy S. Diamond (PI).
Affiliation: Drexel University.
email: gd342@drexel.edu
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Diamond 2014 (Continued)
Notes Dr. Suzanne Levy and Dr. Guy Diamond very kindly provided unpublished information relating to this trial.
Additionally, Dr. Levy provided the following notes pertaining to the findings of this study:
“In 2011, we completed a pilot study testing the feasibility, acceptability and outcomes of Attachment-
Based Family Therapy (ABFT; Diamond et. al, 2002) as an aftercare model. We aimed to build on the gains
made during inpatient treatment and reduce risk factors for future suicide attempt. Additionally, we sought
to strengthen our partnership with an adolescent inpatient unit, creating an infrastructure for long-term
collaboration in suicide research. Twenty adolescents (80% female, 65% identified as African American),
with mean age of 14.9 years, and a parent/caregiver were recruited from inpatient care following a suicide
attempt. Of the parents, 8 (40%) had an income under $30,000, 14 (70%) were single or separated/divorced,
and 7 (35%) had no more than a high school education. Families were randomised to 16 weeks of either
ABFT or Enhanced Usual Care (EUC). As a result of variety of means to build a relationship with a local
psychiatric hospital (meeting with hospital staff, holding case conferences, quick response time to referrals
[intake within 48 hours of discharge], follow-up post referral, and hosting free educational presentations) we
were able to successfully join with the hospital and create a lasting research infrastructure to support future
research projects. ABFT was a welcomed option by all of the social workers, nurses, and psychiatrists on the
inpatient unit. In terms of feasibility, we met our recruitment goals, the majority of families were interested in
receiving family therapy (74% of those referred) and those that got ABFT attended sessions regularly (mean =
11.2 sessions). Additionally, we were able to collect weekly data from participants the majority of the time and
collect post treatment data from 90% of the participants. Participants receiving ABFT indicated they were
marginally statistically significantly more satisfied with treatment than those receiving EUC (t(12)=2.02, p=
0.07). Related to effectiveness, results show that compared to EUC, ABFT was marginally significantly more
effective at preventing future suicide attempts (0% ABFT, 16.7% EUC Chi(1)=3.60,p=0.058; Fisher’s exact
p=0.206), reducing attachment related avoidance for mothers (F(1,9)=3.85, p=0.08), and ABFT participants
received treatment faster than EUC participants (t(6)=-2.09, p=.08). Additionally, ABFT compared to EUC,
was statistically more effective at reducing attachment related anxiety for fathers (F(1,3)=12.33, p=0.04).
Overall, the results of this study demonstrate that ABFT is both a feasible and acceptable treatment as aftercare
for youth with a suicide attempt after discharge from inpatient care.”
Fischer 2013
Trial name or title Short-term psychotherapeutic treatment in adolescents engaging in non-suicidal self-injury
Trial Registration Number: DRKS00003605.
Methods Allocation: single-blinded randomisation.
Design: single-centre (community adolescent mental health clinic).
Setting: community.
Follow-up period: 6 months post line.
Location: Heidelberg, Germany.
Participants Male and female adolescents, between 12 and 17 years of age, who had engaged in five or more episodes
of nonsuicidal self-injury in the 6 months prior to randomisation, with at least one episode within the one
month prior to screening, will be included in this trial
Expected N: 80.
Interventions Participants randomised to the experimental group will receive a crisis card and 8-12 weekly sessions of
individual psychotherapy using the German version of the Cutting Down Programme
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Fischer 2013 (Continued)
Outcomes Primary outcome: 50% (ormore) reduction in frequency of self-harm as assessed by the Self-InjuriousThoughts
and Behaviors Interview-German version
Secondary outcomes: scores on the Beck Depression Inventory, scores on the KIDSCREEN well being scale,
and scores on the Self-Esteem scale
Starting date November, 2012.
Proposed end date: May, 2015.
Contact information Name: Dr. Michael Kaess (PI).
Affiliation: Department of Child and Adolescent Psychiatry, Center of Psychosocial Medicine, University of
Heidelberg
email: michael.kaess@med.uni-heidelberg.de
Notes Dr. Michael Kaess very kindly provided unpublished information relating to this trial
Linehan 2014
Trial name or title Collaborative Adolescent Research on Emotions and Suicide (CARES)
Trial Registration Number: NCT01528020.
Methods Allocation: single-blind randomisation.
Design: multi-centre (community clinics).
Setting: community outpatient clinics.
Location: Seattle, WA and Los Angeles, CA, USA.
Participants Males and females, between 12 and 18 years of age, diagnosed with emotional dysregulation, who made
a suicide attempt and/or engaged in self-harm within 6 months prior to randomisation will be eligible for
inclusion in this study
Interventions Individuals randomised to the experimental group will receive dialectical behavior therapy and individual and
group supportive therapy
Outcomes Primary outcomes: repetition of any suicidal behaviour, defined as a suicide attempt, suicide, or self-injury
with suicide intent or ambivalent intent as measured by the SASII, admission to the emergency department or
inpatient psychiatric facilities for suicidality as measured by the Columbia Classification Algorithm of Suicide
Assessment, days successfully retained in treatment, and quality of family relationships as measured by the
child bipolar questionnaire
Secondary outcomes: number of episodes of non-suicidal self-injury as measured by the SASII, the highest
medical risk and risk/rescue score as measured by the SASII, number of suicidal threats made measured by
the Suicide Behaviors Questionnaire-Revised, and the level of suicidal ideation as measured by the Suicide
IdeationQuestionnaire-Junior, number who drop-out of treatment prematurely, number of treatment sessions
attended, number of times late to treatment sessions, number of times treatment sessions left early, scores on the
adolescent global functioning scale of the Children’s Global Assessment Scale, scores on the depression scale of
the Children’s Depression Inventory, scores on the anger control, bullying, emotional self-control, aggression,
emotion regulation, and resiliency scales of theBehaviorAssessment System forChildren, SecondEdition, Buss
Perry Aggression Questionnaire, and Difficulties in Emotion Regulation Scale, scores on the impulsiveness
and substance abuse scales of the Barratt Impulsiveness Scale, and the Daily Drinking Questionnaire, scores
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on the social adjustment scale of the Social Adjustment Scale-Self-Report, and school attendance as measured
by school records
Starting date January, 2012.
Proposed End Date: January, 2016.
Contact information Name: Prof. Marsha M. Linehan (PI).
Affiliation: Behavioural Research and Therapy Clinics, University of Washington
email: linehan@uw.edu
Notes Ms. Elaine Franks, personal assistant to Marsha Linehan, very kindly provided unpublished information
relating to this trial. Ms. Franks also provided the following note about this trial:
“...insufficient males have been enrolled and will be removed from the final data set and later presented as a
sub-study.”
NSSI: non-suicidal self injury
SASII: Suicide Attempt Self Injury Interview
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D A T A A N D A N A L Y S E S
Comparison 1. Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine
management
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH
post-intervention
3 Odds Ratio (M-H, Random, 95% CI) Subtotals only
1.1 DBT-A 2 105 Odds Ratio (M-H, Random, 95% CI) 0.72 [0.12, 4.40]
1.2 Mentalisation 1 71 Odds Ratio (M-H, Random, 95% CI) 0.26 [0.09, 0.78]
2 Frequency of SH
post-intervention
2 104 Mean Difference (IV, Random, 95% CI) -0.79 [-2.78, 1.20]
2.1 DBT-A 2 104 Mean Difference (IV, Random, 95% CI) -0.79 [-2.78, 1.20]
3 Number of individual
psychotherapy sessions
attended
2 106 Mean Difference (IV, Random, 95% CI) 9.14 [-4.39, 22.66]
3.1 DBT-A 2 106 Mean Difference (IV, Random, 95% CI) 9.14 [-4.39, 22.66]
4 Number of family therapy
sessions attended
2 106 Mean Difference (IV, Random, 95% CI) 0.93 [-7.01, 8.86]
4.1 DBT-A 2 106 Mean Difference (IV, Random, 95% CI) 0.93 [-7.01, 8.86]
5 Number completing full course
of treatment
1 80 Odds Ratio (M-H, Random, 95% CI) 1.35 [0.56, 3.27]
5.1 Mentalisation 1 80 Odds Ratio (M-H, Random, 95% CI) 1.35 [0.56, 3.27]
6 Depression scores
post-intervention
2 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 DBT-A 1 77 Mean Difference (IV, Random, 95% CI) -2.39 [-5.02, 0.24]
6.2 Mentalisation 1 80 Mean Difference (IV, Random, 95% CI) -2.28 [-2.81, -1.75]
7 Hopelessness scores
post-intervention
2 101 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.93, 0.67]
7.1 DBT-A 2 101 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.93, 0.67]
8 Suicidal ideation scores
post-intervention
2 100 Std. Mean Difference (IV, Random, 95% CI) -0.62 [-1.07, -0.16]
8.1 DBT-A 2 100 Std. Mean Difference (IV, Random, 95% CI) -0.62 [-1.07, -0.16]
Comparison 2. Group-based psychotherapy vs. Treatment as usual or other routine management
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Repetition of SH at six months 2 430 Odds Ratio (M-H, Random, 95% CI) 1.72 [0.56, 5.24]
2 Repetition of SH at 12 months 3 490 Odds Ratio (M-H, Random, 95% CI) 0.80 [0.22, 2.97]
3 Depression scores at six months 2 420 Mean Difference (IV, Random, 95% CI) 0.40 [-2.76, 3.55]
4 Depression scores at 12 months 3 473 Mean Difference (IV, Random, 95% CI) -0.93 [-4.03, 2.17]
5 Suicidal ideation scores at six
months
2 421 Mean Difference (IV, Random, 95% CI) 1.27 [-7.74, 10.28]
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6 Suicidal ideation scores at 12
months
3 471 Mean Difference (IV, Random, 95% CI) -1.51 [-9.62, 6.59]
Analysis 1.1. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 1 Repetition of SH post-intervention.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 1 Repetition of SH post-intervention
Study or subgroup DBT-A/Mentalisaiton Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 DBT-A
Cooney 2010 2/13 1/15 34.9 % 2.55 [ 0.20, 31.86 ]
Mehlum 2014 3/39 7/38 65.1 % 0.37 [ 0.09, 1.55 ]
Subtotal (95% CI) 52 53 100.0 % 0.72 [ 0.12, 4.40 ]
Total events: 5 (DBT-A/Mentalisaiton), 8 (Control)
Heterogeneity: Tau2 = 0.77; Chi2 = 1.70, df = 1 (P = 0.19); I2 =41%
Test for overall effect: Z = 0.35 (P = 0.73)
2 Mentalisation
Rossouw 2012a 20/36 29/35 100.0 % 0.26 [ 0.09, 0.78 ]
Subtotal (95% CI) 36 35 100.0 % 0.26 [ 0.09, 0.78 ]
Total events: 20 (DBT-A/Mentalisaiton), 29 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.41 (P = 0.016)
0.1 0.2 0.5 1 2 5 10
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Analysis 1.2. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 2 Frequency of SH post-intervention.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 2 Frequency of SH post-intervention
Study or subgroup DBT-A Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 DBT-A
Cooney 2010 12 0.67 (0.79) 15 0.67 (1.59) 62.5 % 0.0 [ -0.92, 0.92 ]
Mehlum 2014 39 1.2 (2) 38 3.3 (6.8) 37.5 % -2.10 [ -4.35, 0.15 ]
Total (95% CI) 51 53 100.0 % -0.79 [ -2.78, 1.20 ]
Heterogeneity: Tau2 = 1.44; Chi2 = 2.86, df = 1 (P = 0.09); I2 =65%
Test for overall effect: Z = 0.78 (P = 0.44)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours intervention Favours control
87Interventions for self-harm in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.3. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 3 Number of individual psychotherapy sessions attended.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 3 Number of individual psychotherapy sessions attended
Study or subgroup DBT-A Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 DBT-A
Cooney 2010 14 22.6 (6.4) 15 6.5 (4.1) 49.5 % 16.10 [ 12.16, 20.04 ]
Mehlum 2014 39 13.8 (6.9) 38 11.5 (6.4) 50.5 % 2.30 [ -0.67, 5.27 ]
Total (95% CI) 53 53 100.0 % 9.14 [ -4.39, 22.66 ]
Heterogeneity: Tau2 = 92.05; Chi2 = 30.01, df = 1 (P<0.00001); I2 =97%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.4. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 4 Number of family therapy sessions attended.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 4 Number of family therapy sessions attended
Study or subgroup DBT-A Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 DBT-A
Cooney 2010 14 8 (3.1) 15 3.1 (3.3) 50.9 % 4.90 [ 2.57, 7.23 ]
Mehlum 2014 39 2.6 (2.2) 38 5.8 (9.8) 49.1 % -3.20 [ -6.39, -0.01 ]
Total (95% CI) 53 53 100.0 % 0.93 [ -7.01, 8.86 ]
Heterogeneity: Tau2 = 30.77; Chi2 = 16.14, df = 1 (P = 0.00006); I2 =94%
Test for overall effect: Z = 0.23 (P = 0.82)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 5 Number completing full course of treatment.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 5 Number completing full course of treatment
Study or subgroup Mentalisation Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Mentalisation
Rossouw 2012a 20/40 17/40 100.0 % 1.35 [ 0.56, 3.27 ]
Total (95% CI) 40 40 100.0 % 1.35 [ 0.56, 3.27 ]
Total events: 20 (Mentalisation), 17 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
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Analysis 1.6. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 6 Depression scores post-intervention.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 6 Depression scores post-intervention
Study or subgroup DBT-A/Mentalisation Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 DBT-A
Mehlum 2014 39 10.19 (5.04) 38 12.58 (6.62) 100.0 % -2.39 [ -5.02, 0.24 ]
Subtotal (95% CI) 39 38 100.0 % -2.39 [ -5.02, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.78 (P = 0.075)
2 Mentalisation
Rossouw 2012a 40 9.26 (1.27) 40 11.54 (1.14) 100.0 % -2.28 [ -2.81, -1.75 ]
Subtotal (95% CI) 40 40 100.0 % -2.28 [ -2.81, -1.75 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.45 (P < 0.00001)
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Analysis 1.7. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 7 Hopelessness scores post-intervention.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 7 Hopelessness scores post-intervention
Study or subgroup DBT-A Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 DBT-A
Cooney 2010 12 -4.28 (1.27) 12 -4.7 (1) 41.5 % 0.35 [ -0.45, 1.16 ]
Mehlum 2014 39 6.23 (5.3) 38 9.06 (6.53) 58.5 % -0.47 [ -0.93, -0.02 ]
Total (95% CI) 51 50 100.0 % -0.13 [ -0.93, 0.67 ]
Heterogeneity: Tau2 = 0.23; Chi2 = 3.06, df = 1 (P = 0.08); I2 =67%
Test for overall effect: Z = 0.32 (P = 0.75)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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Analysis 1.8. Comparison 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as
usual or other routine management, Outcome 8 Suicidal ideation scores post-intervention.
Review: Interventions for self-harm in children and adolescents
Comparison: 1 Dialectical behaviour therapy/mentalisation for adolescents vs. Treatment as usual or other routine management
Outcome: 8 Suicidal ideation scores post-intervention
Study or subgroup DBT-A Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 DBT-A
Cooney 2010 10 5 (8.87) 13 7.23 (9.12) 27.3 % -0.24 [ -1.07, 0.59 ]
Mehlum 2014 39 18.3 (11.11) 38 32.56 (23.99) 72.7 % -0.76 [ -1.22, -0.30 ]
Total (95% CI) 49 51 100.0 % -0.62 [ -1.07, -0.16 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 1.15, df = 1 (P = 0.28); I2 =13%
Test for overall effect: Z = 2.66 (P = 0.0078)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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Analysis 2.1. Comparison 2 Group-based psychotherapy vs. Treatment as usual or other routine
management, Outcome 1 Repetition of SH at six months.
Review: Interventions for self-harm in children and adolescents
Comparison: 2 Group-based psychotherapy vs. Treatment as usual or other routine management
Outcome: 1 Repetition of SH at six months
Study or subgroup
Group-based
psychother-
apy TAU Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Green 2011 145/181 142/181 62.6 % 1.11 [ 0.67, 1.84 ]
Hazell 2009 30/34 23/34 37.4 % 3.59 [ 1.01, 12.73 ]
Total (95% CI) 215 215 100.0 % 1.72 [ 0.56, 5.24 ]
Total events: 175 (Group-based psychotherapy), 165 (TAU)
Heterogeneity: Tau2 = 0.45; Chi2 = 2.86, df = 1 (P = 0.09); I2 =65%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Group-based psychotherapy vs. Treatment as usual or other routine
management, Outcome 2 Repetition of SH at 12 months.
Review: Interventions for self-harm in children and adolescents
Comparison: 2 Group-based psychotherapy vs. Treatment as usual or other routine management
Outcome: 2 Repetition of SH at 12 months
Study or subgroup Group-based psych TAU Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Green 2011 104/179 110/180 42.4 % 0.88 [ 0.58, 1.35 ]
Hazell 2009 30/34 24/34 31.2 % 3.13 [ 0.87, 11.21 ]
Wood 2001a 2/32 10/31 26.4 % 0.14 [ 0.03, 0.71 ]
Total (95% CI) 245 245 100.0 % 0.80 [ 0.22, 2.97 ]
Total events: 136 (Group-based psych), 144 (TAU)
Heterogeneity: Tau2 = 1.00; Chi2 = 8.75, df = 2 (P = 0.01); I2 =77%
Test for overall effect: Z = 0.33 (P = 0.74)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
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Analysis 2.3. Comparison 2 Group-based psychotherapy vs. Treatment as usual or other routine
management, Outcome 3 Depression scores at six months.
Review: Interventions for self-harm in children and adolescents
Comparison: 2 Group-based psychotherapy vs. Treatment as usual or other routine management
Outcome: 3 Depression scores at six months
Study or subgroup Group-based psych TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Green 2011 171 28.5 (16.1) 178 27.6 (16.5) 85.0 % 0.90 [ -2.52, 4.32 ]
Hazell 2009 34 31.6 (17.45) 37 34.05 (17.49) 15.0 % -2.45 [ -10.58, 5.68 ]
Total (95% CI) 205 215 100.0 % 0.40 [ -2.76, 3.55 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.55, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Group-based psychotherapy vs. Treatment as usual or other routine
management, Outcome 4 Depression scores at 12 months.
Review: Interventions for self-harm in children and adolescents
Comparison: 2 Group-based psychotherapy vs. Treatment as usual or other routine management
Outcome: 4 Depression scores at 12 months
Study or subgroup Group-based psych TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Green 2011 170 24.4 (16.6) 174 24.6 (17.6) 73.6 % -0.20 [ -3.81, 3.41 ]
Hazell 2009 34 27.4 (17.16) 37 31.76 (18.91) 13.7 % -4.36 [ -12.75, 4.03 ]
Wood 2001a 29 21.9 (15.6) 29 23.4 (18) 12.8 % -1.50 [ -10.17, 7.17 ]
Total (95% CI) 233 240 100.0 % -0.93 [ -4.03, 2.17 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.82, df = 2 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.59 (P = 0.55)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Group-based psychotherapy vs. Treatment as usual or other routine
management, Outcome 5 Suicidal ideation scores at six months.
Review: Interventions for self-harm in children and adolescents
Comparison: 2 Group-based psychotherapy vs. Treatment as usual or other routine management
Outcome: 5 Suicidal ideation scores at six months
Study or subgroup Group-based psych TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Green 2011 171 61.5 (45.5) 179 59.9 (48.4) 83.9 % 1.60 [ -8.24, 11.44 ]
Hazell 2009 34 68.94 (44.92) 37 69.38 (51.42) 16.1 % -0.44 [ -22.86, 21.98 ]
Total (95% CI) 205 216 100.0 % 1.27 [ -7.74, 10.28 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.28 (P = 0.78)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
Favours group-based psych Favours TAU
97Interventions for self-harm in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.6. Comparison 2 Group-based psychotherapy vs. Treatment as usual or other routine
management, Outcome 6 Suicidal ideation scores at 12 months.
Review: Interventions for self-harm in children and adolescents
Comparison: 2 Group-based psychotherapy vs. Treatment as usual or other routine management
Outcome: 6 Suicidal ideation scores at 12 months
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Green 2011 169 48.3 (42.7) 174 49.2 (46.8) 73.2 % -0.90 [ -10.38, 8.58 ]
Hazell 2009 34 59.78 (42.07) 37 61.68 (49.62) 14.4 % -1.90 [ -23.24, 19.44 ]
Wood 2001a 28 41.3 (39.6) 29 46 (48.9) 12.4 % -4.70 [ -27.76, 18.36 ]
Total (95% CI) 231 240 100.0 % -1.51 [ -9.62, 6.59 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.09, df = 2 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.37 (P = 0.71)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Methods used for the index episode of self-harm in included studies
Reference Method 1
Self-poisoning
(any)
n (%)
Self-poisoning
(alcohol)
n (%)
Self-injury
(any)
n (%)
Combined self-
poisoning
and self-injury
n (%)
Cotgrove 19952 94 (89.6) 7 (6.6) 2 (1.9)
Donaldson 20053 33 (84.6)
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Table 1. Methods used for the index episode of self-harm in included studies (Continued)
Green 2011 5 (2.7) 67 (36.6) 111 (60.7)
Harrington 1998 162 (100)
Ougrin 2011a 28 (40.0) 37 (52.8) 5 (7.2)
Spirito 20024 54 (85.7)
1 Refers to method used for the index episode.
2 The method used by the remaining two (1.9%) participants was not reported.
3 The method used by the remaining six (15.4%) participants was not reported.
4 The method used by the remaining nine (14.3%) participants was not reported.
Table 2. Psychiatric diagnoses in included studies
Refer-
ence
Psychiatric diagnosis1
Major
depres-
sion
n (%)
Any
other
mood
disor-
der
n (%)
Any
anxiety
disor-
der
n (%)
Post-
trau-
matic
stress
disor-
der
n (%)
Any
eating
disor-
der
n (%)
Alcohol
use
disor-
der/
depen-
dence
n (%)
Drug
use
disor-
der/
depen-
dence
n (%)
Sub-
stance
use
disor-
der/
depen-
dence
n (%)
Oppo-
sitional
defi-
ance
disor-
der
n (%)
Con-
duct
disor-
der
n (%)
Any
other
be-
haviour
disor-
der
n (%)
Border-
line
person-
ality
disor-
der
n (%)
Cooney
2010
23 (79.
3)
24 (82.
7)
7 (24.1) 9 (31.0) 8 (27.6)
Cot-
grove
1995
Information on psychiatric diagnosis not provided.
Don-
aldson
2005
9 (29.0) 6 (19.3) 14 (45.
2)
14 (45.
2)
Green
2011
227
(62.0)
122
(22.2)
Har-
rington
1998
109
(67.3)
17 (10.
5)
Hazell
2009
41 (56.
9)
3 (4.2) 5 (6.9)2
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Table 2. Psychiatric diagnoses in included studies (Continued)
Mehlum
2014
17 (22.
1)
29 (37.
7)
33 (42.
9)
13 (16.
9)
6 (7.8) 2 (2.6) 15 (20.
5)
Ougrin
2011a3
Rossouw
2012a
77 (96.
2)
35 (43.
7)
27.5
(28.0)
58 (72.
5)
Spirito
20024
1 (2.2) 6 (13.0) 4 (8.7) 6 (13.0) 5 (10.9) 6 (13.0)
Wood
2001a
52 (83.
9)
42 (68.
8)2
1 All diagnoses refer to current, rather than lifetime, diagnoses. The total percentages were more than 100% in some studies due to
comorbidity.
2 Conduct disorder or oppositional defiance disorder.
3 The authors state that 53/70 (75.7%) participants had previous contact with mental health services. Diagnoses are only provided
in broad categories, however. Specifically, 42/70 (60.0%) were diagnosed with an “emotional disorder,” 9/70 (12.8%) were diagnosed
with a “disruptive disorder,” and 2/70 (2.8%) were diagnosed with “another disorder.”
4 Information on psychiatric diagnoses were available for only 46 of the 63 participants.
A P P E N D I C E S
Appendix 1. CCDANCTR Search Strategy
Search Strategy 1956 to 2015:
CCDANCTR
Date range searched: 01.01.56 to 30.01.15.
#1. ((deliberat* or self*) NEXT (destruct* or harm* or injur* or mutilat* or poison*)):ab,ti,kw,ky,emt,mh,mc
#2. DSH:ab
#3. (parasuicid* or “para suicid*”)
#4. (suicid* NEAR2 (attempt* or episod* or frequen* or future or histor* or multiple or previous* or recur* or repeat* or repetition)):
ab,ti,kw,ky,emt,mh,mc
#5. “post suicid*”
#6. (suicid* and (BPD or “borderline personality disorder”))
#7. (overdos* or “over dos*”)
#8. ((crisis or suicid*) NEAR (emergenc* or hospital or outpatient or “repeat* attend*” or “frequent* attend*” )):ab,ti,kw,ky,emt,mh,mc
#9. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8)
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Notes: ab: abstract; ti: title; kw: keywords; ky: additional keywords; emt: EMTREE headings; mh: MeSH headings; mc: MeSH
checkwords.
Appendix 2. EMBASE, MEDLINE, PreMEDLINE, PsycINFO and CENTRAL Search Strategies
Search Strategy 1998 to 2013:
EMBASE, MEDLINE, PreMEDLINE, PsycINFO (OVID SP interface)
Date range searched: 01.01.1998 to 13.10.2013.
1. automutilation/ or drug overdose/ or exp suicidal behavior/
2. 1 use emez
3. overdose/ or self-injurious behavior/ or self mutilation/ or suicide/ or suicidal ideation/ or suicide, attempted/
4. 3 use mesz, prem
5. drug overdoses/ or self destructive behavior/ or exp self injurious behavior/ or attempted suicide/ or suicidal ideation/ or suicide/ or
suicide prevention/ or suicide prevention centers/ or suicidology/
6. 5 use psyh
7. (auto mutilat$ or automutilat$ or cutt$ or head bang$ or head bang$ or overdos$ or (self adj2 cut$) or self destruct$ or selfdestruct$
or self harm$ or selfharm$ or self immolat$ or selfimmolat$ or self inflict$ or selfinflict$ or self injur$ or selfinjur$ or selfmutilat$ or
self mutilat$ or self poison$ or selfpoison$ or suicid$).ti,ab.
8. or/2,4,6-7
9. exp “clinical trial (topic)”/ or exp clinical trial/ or crossover procedure/ or double blind procedure/ or placebo/ or randomization/ or
random sample/ or single blind procedure/
10. 9 use emez
11. exp clinical trial/ or exp “clinical trials as topic”/ or cross-over studies/ or double-blind method/ or placebos/ or random allocation/
or single-blind method/
12. 11 use mesz, prem
13. (clinical trials or placebo or random sampling).sh,id.
14. 13 use psyh
15. (clinical adj2 trial$).ti,ab.
16. (crossover or cross over).ti,ab.
17. (((single$ or doubl$ or trebl$ or tripl$) adj2 blind$) or mask$ or dummy or doubleblind$ or singleblind$ or trebleblind$ or
tripleblind$).ti,ab.
18. (placebo$ or random$).ti,ab.
19. treatment outcome$.md. use psyh
20. animals/ not human$.mp. use emez
21. animal$/ not human$/ use mesz
22. (animal not human).po. use psyh
23. (or/10,12,14-19) not (or/20-22)
24. 8 and 23
CENTRAL (Wiley interface)
Date range searched: 01.01.1998 to 13.10.2013.
#1. MeSH descriptor: [Drug Overdose], this term only
#2. MeSH descriptor: [Self-Injurious Behavior], this term only
#3. MeSH descriptor: [Self Mutilation], this term only
#4. MeSH descriptor: [Suicide], this term only
#5. MeSH descriptor: [Suicide, Attempted], this term only
#6. MeSH descriptor: [Suicidal Ideation], this term only
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#7. auto mutilat*“ or automutilat* or cutt* or ”head bang*“ or headbang* or overdos* or ”self destruct*“ or selfdestruct* or ”self
harm*“ or selfharm* or ”self immolat*“ or selfimmolat* or ”self inflict*“ or selfinflict* or ”self injur*“ or selfinjur* or selfmutilat* or
”self mutilat*“ or ”self poison*“ or selfpoison* or suicid*:ti
#8. ”auto mutilat*“ or automutilat* or cutt* or ”head bang*“ or ”head bang*“ or overdos* or ”self destruct*“ or selfdestruct* or ”self
harm*“ or selfharm* or ”self immolat*“ or selfimmolat* or ”self inflict*“ or selfinflict* or ”self injur*“ or selfinjur* or selfmutilat* or
”self mutilat*“ or ”self poison*“ or selfpoison* or suicid*:ab
#9. #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8
Appendix 3. Journals hand-searched for relevant literature in the original version of this review
1. Archives of Suicide Research (1995-1998);
2.Crisis (1980-1998);
3. Suicide and Life-Threatening Behavior (1971-1998);
4. Der Nervenarzt (1950-1979);
5. Journal of Adolescence (1978-1996);
6. Journal of Affective Disorders (1994-1996);
7. Journal of the American Academy of Child and Adolescent Psychiatry (1978-1996);
8. Journal of Clinical Psychiatry (1978-1996);
9. Journal of Psychiatric Research (1961-1972) and (1985-1996);
10. Social Psychiatry (1966-1987), and
11. Social Psychiatry & Psychiatric Epidemiology (1988-1996).
Appendix 4. Data collection and analysis methods used for the original review
Selection of studies
In the original version of this review, Sarah Stockton, Librarian at the University of Oxford, conducted the systematic search for trials.
Two out of TTS, EA, ET, and KH then independently screened the titles of identified trials for relevancy. A distinction was made
between:
1) eligible studies, in which any psychological and/or psychopharmacological treatment was compared with a control (e.g. standard or
less intensive types of aftercare or medication), and;
2) ineligible general treatment studies, without any control treatment.
A second screening was then undertaken in which two of TTS, EA, ET, and KH independently screened the full text of relevant studies
with reference to the following inclusion criteria:
1. All participants must have engaged in SH (self-poisoning or self-injury) shortly prior to randomisation;
2. Studies must have reported the number of participants engaging in a repeat episode of SH as an outcome measure;
3. Study participants must have been randomised to the treatment and control groups.
Data extraction and management
Data extraction was carried out by EA and second member of the review group (TTS, ET, or KH) using a standardised data extraction
form.Members of the review team extracted data independently fromone another.Disputes were resolved through consensus discussions
with a third member of the review group, with assistance from the CCDAN editorial base.
We extracted data from each eligible trial concerning the characteristics of patients, the details of the interventions used, and information
on the number of participants engaging in a repeat episode of SH during the follow-up period. Where these details were unclear,
corresponding authors were contacted to provide additional clarification.
Assessment of risk of bias
For the original version of this review, the quality of the studies was rated by three independent review authors (EA and ET plus another
member of the review group). Review authors were blind to authorship according to the recommended Cochrane criteria for quality
assessment (Sackett 1997).
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Given that the quality of concealment of allocation can affect the results of trials (Schulz 1995), studies were assigned a quality of
concealment rating ranging from C (poor quality) to A (high quality). Trials rated as inadequately concealed, for example via reference
to an open random number table, were given a rating of C. Trials that did not provide adequate details about how the randomisation
procedure was carried out were given a rating of B, and trials that were deemed to have taken adequate measures to conceal allocation,
for example through the use of serially numbered, opaque, sealed envelopes and numbered or coded bottles or containers, were rated
as A quality. Where the concealment of allocation was not clearly reported (i.e. where trials were initially in category B), we contacted
corresponding authors for more information. Where raters disagreed as to the category to which a trial should be been allocated, the
final rating was made by consensus discussion in consultation with TTS, KH, and a third member of the review group.
Measures of treatment effect
RevMan, version 3.0, was used to calculate summary odds ratios and accompanying 95% CIs for the number of participants engaging
in a repeat episode of SH during the follow-up period.
Unit of analysis issues
1. Cluster trials
Clustering was an issue in one included study (Bennewith 2002), however, as the authors reported adjusting for the effects of clustering
in their primary analyses, we reproduced the data from this study as if it came from a non-cluster randomised study.
2. Studies with multiple treatment groups
One included study presented data for multiple treatment groups (Hirsch 1982). As both treatment groups were prescribed antide-
pressants in this study, we combined the data from these two treatment arms.
Dealing with missing data
Where data on the primary outcome measure were incomplete or excluded from the study, corresponding author(s) were contacted
to obtain further information. Some authors used intention to treat analyses to account for missing data using a variety of different
methods which are discussed within the ’Risk of bias’ tables. We as review authors did not attempt to impute data for those studies in
which intention-to-treat analyses had not been conducted, however. Instead, the effects of missing data were discussed in the text of
the review.
Assessment of heterogeneity
Clinical heterogeneity was examined using the Chi2 test. Where this statistic was significant, potential causes of heterogeneity were
investigated as outlined in the ”Subgroup analysis and investigation of heterogeneity“ section below.
Assessment of reporting biases
To assess whether any meta-analysis reported in this review are affected by reporting bias, we planned to construct funnel plots to
investigate the likelihood that the results of our meta-analysis were affected by reporting bias. We were unable to undertake these
analyses, however, due to the very small number of trials included in our meta-analyses.
Data synthesis
The Mantel-Haenszel fixed-effect method was used to calculate pooled summary ORs and accompanying 95% CIs.
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Subgroup analysis and investigation of heterogeneity
In analyses resulting in significant heterogeneity, as indicated by the Chi2 test, an investigation into the source of this heterogeneity
was conducted. We had planned to conduct subgroup analyses by repeater status and gender, however, there were insufficient studies
with appropriate data to enable these analyses to be undertaken.
Sensitivity analysis
Sensitivity analyses were undertaken where appropriate (e.g., in relation to risk of bias of included trials in the relative intensity of
treatment).
WH A T ’ S N E W
Date Event Description
5 January 2016 Amended Minor edit to title of analysis 1.
C O N T R I B U T I O N S O F A U T H O R S
KH had the idea for the review. All authors extracted data and assessed risk of bias for included studies. Both TTS and KW conducted
the statistical analyses. KH, TTS, and KW wrote the initial version of the report and all authors contributed to the writing of drafts.
All authors also approved the final version of the review for publication.
D E C L A R A T I O N S O F I N T E R E S T
PH is the author of one of the trials included in the review.
S O U R C E S O F S U P P O R T
Internal sources
• University Department of Psychiatry, Warneford Hospital, Oxford, UK.
• Oxford Health NHS Foundation Trust, UK.
External sources
• NHS Executive Anglia and Oxford Research and Development Program, UK.
• NIHR Service Delivery and Organisation programme, UK.
• Personal funding to KH as an NIHR Senior Investigator, UK.
104Interventions for self-harm in children and adolescents (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In the original protocol for this review, we planned to assess dichotomous outcome data (i.e., repetition of self-harm and suicide) using
the Peto odds ratio. Following revisions to iterations of the Cochrane Handbook (Higgins 2011) and new statistical advice, however,
we have instead used the Mantel-Haenszel method in this update. For this version of the review we have also expanded the range of
outcomes assessed to include depression, hopelessness, problem-solving, and suicidal ideation. We have also used the I2 statistic, rather
than the Chi2 test, to summarise between-study heterogeneity in this version in light of revisions to the Cochrane Handbook (Higgins
2011).
We also planned to assess methodological quality of included trials by the means recommended by the contemporary version of
theCochrane Handbook (Higgins 2011). For this version of the review we have therefore created ’Risk of bias’ and ’Summary of findings’
tables as per current recommendations. We have also refined the unit of analysis section, as per current recommendations, to include
Zelen designed trials and trials that report adjusted effect sizes.
We have also added three sensitivity analyses: one for trials which employed Zelen’s method of randomisation; one for trials that
contributed to substantial (> 75%) levels of heterogeneity; and a third for trials that included a small minority (< 15%) of adult
participants. Given the increasing use of enhanced usual care, rather than TAU, in trials in this area, we also added one sub-group
analysis to determine whether comparator choice influenced the pattern of results observed.
As we were unable to rank outcomes in a hierarchy in the present review, and given the absence of consensus rankings particularly
for hopelessness, suicidal ideation, and problem-solving, we have instead used the most common measure in any meta-analysis and
report results from any other measure in the text of the review. In future updates of this review, we will adopt any accepted outcome
hierarchies.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Anti-Anxiety Agents [therapeutic use]; Antidepressive Agents [∗therapeutic use]; Antipsychotic Agents [∗therapeutic use]; Behavior
Therapy [methods]; Family Therapy; Patient Compliance [statistics & numerical data]; Problem Solving; Psychotherapy [∗methods];
Psychotherapy, Group; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention [methods]; Self-Injurious Behavior
[∗prevention & control; psychology]; Suicide [prevention & control]; Theory of Mind
MeSH check words
Adolescent; Child; Female; Humans; Male
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